SARS-CoV-2 Infection Dysregulates Host Iron (Fe)-Redox Homeostasis (Fe-R-H): Role of Fe-Redox Regulators, Ferroptosis Inhibitors, Anticoagulants, and Iron-Chelators in COVID-19 Control

References

• World Health Organization. Coronavirus (COVID) Dashboard. (accessed on Apr 19, 2022). https://covid19.who.int/info/.
   Google Scholar
• WHO. Coronaviruses. 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/transcripts/who-audio-emergencies-coronavirus-press-conference-20apr2020.pdf?sfvrsn=b5656a70_2. Last accessed: 19th Nov 2021.
   Google Scholar
• Naidu SAG, Mustafa G, Clemens RA, Naidu AS. Plant-derived natural non-nucleoside analog inhibitors (NNAIs) against RNA-dependent RNA polymerase complex (nsp7/nsp8/nsp12) of SARS-CoV-2. J Diet Suppl. 2021;1:1–30. Epub ahead of print. PMID: 34850656. doi:10.1080/19390211.2021.2006387.
   Google Scholar
• Krumm ZA, Lloyd GM, Francis CP, Nasif LH, Mitchell DA, Golde TE, Giasson BI, Xia Y. Precision therapeutic targets for COVID-19. Virol J. 2021;18(1):66. doi: 10.1186/s12985-021-01526-y. PMID: 33781287; PMCID: PMC8006140.
   PubMed Web of Science ®Google Scholar
• Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, Psaltopoulou T, Gerotziafas G, Dimopoulos MA. Hematological findings and complications of COVID-19. Am J Hematol. 2020;95(7):834–47. doi:10.1002/ajh.25829. Epub 2020 May 23. PMID: 32282949; PMCID: PMC7262337.
   PubMed Web of Science ®Google Scholar
• Naidu SAG, Wallace TC, Davies KJA, Naidu AS. Lactoferrin for mental health: neuro-redox regulation and neuroprotective effects across the blood-brain barrier with special reference to neuro-COVID-19. J Diet Suppl. 2021:1–35. Epub ahead of print. PMID: 33977807. doi:10.1080/19390211.2021.1922567.
   Google Scholar
• Sicari D, Chatziioannou A, Koutsandreas T, Sitia R, Chevet E. Role of the early secretory pathway in SARS-CoV-2 infection. J Cell Biol. 2020;219(9):e202006005. doi:10.1083/jcb.202006005.Erratum in: J Cell Biol. 2020 Sep 7;219(9): PMID: 32725137; PMCID: PMC7480111.
   PubMed Web of Science ®Google Scholar
• Cavezzi A, Troiani E, Corrao S. COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review. Clin Pract. 2020;10(2):1271. doi:10.4081/cp.2020.1271. PMID: 32509258; PMCID: PMC7267810.
   PubMed Web of Science ®Google Scholar
• Serebrovska ZO, Chong EY, Serebrovska TV, Tumanovska LV, Xi L. Hypoxia, HIF-1α, and COVID-19: from pathogenic factors to potential therapeutic targets. Acta Pharmacol Sin. 2020;41(12):1539–46. doi:10.1038/s41401-020-00554-8. Epub 2020 Oct 27. PMID: 33110240; PMCID: PMC7588589.
   PubMedGoogle Scholar
• Gómez-Pastora J, Weigand M, Kim J, Wu X, Strayer J, Palmer AF, Zborowski M, Yazer M, Chalmers JJ. Hyperferritinemia in critically ill COVID-19 patients: is ferritin the product of inflammation or a pathogenic mediator? Clin Chim Acta. 2020;509:249–51. doi: 10.1016/j.cca.2020.06.033. Epub 2020 Jun 21. PMID: 32579952; PMCID: PMC7306200.
   PubMed Web of Science ®Google Scholar
• Manson JJ, Crooks C, Naja M, Ledlie A, Goulden B, Liddle T, Khan E, Mehta P, Martin-Gutierrez L, Waddington KE, et al. COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study. Lancet Rheumatol. 2020;2(10):e594–e602. Epub 2020 Aug 21. PMID: 32864628; PMCID: PMC7442426. doi:10.1016/S2665-9913(20)30275-7.
   PubMedGoogle Scholar
• Iba T, Levy JH, Levi M, Thachil J. Coagulopathy in COVID-19. J Thromb Haemost. 2020;18(9):2103–9. doi:10.1111/jth.14975. Epub 2020 Jul 21. PMID: 32558075; PMCID: PMC7323352.
   PubMed Web of Science ®Google Scholar
• Hanff TC, Mohareb AM, Giri J, Cohen JB, Chirinos JA. Thrombosis in COVID-19. Am J Hematol. 2020;95(12):1578–89. doi: 10.1002/ajh.25982. Epub 2020 Sep 16. PMID: 32857878; PMCID: PMC7674272.
   PubMed Web of Science ®Google Scholar
• Sukhomlin T. Hepcidin is a friend rather than a foe in COVID19-induced complications. Acta Biomed. 2020;91(4):e2020138. doi:10.23750/abm.v91i4.10768. PMID: 33525240; PMCID: PMC7927483.
   PubMedGoogle Scholar
• Naidu AS. Redox Life. 1st ed. Yorba Linda (CA): Bio-Rep Media; 2013. ISBN 978–0982445112.
   Google Scholar
• Khodour Y, Kaguni LS, Stiban J. Iron-sulfur clusters in nucleic acid metabolism: Varying roles of ancient cofactors. Enzymes. 2019;45:225–56. doi: 10.1016/bs.enz.2019.08.003. PMID: 31627878.
   PubMedGoogle Scholar
• Edeas M, Saleh J, Peyssonnaux C. Iron: innocent bystander or vicious culprit in COVID-19 pathogenesis? Int J Infect Dis. 2020;97:303–5. doi:10.1016/j.ijid.2020.05.110. Epub 2020 Jun 2. PMID: 32497811; PMCID: PMC7264936.
   PubMed Web of Science ®Google Scholar
• Winter WE, Bazydlo LA, Harris NS. The molecular biology of human iron metabolism. Lab Med. 2014;45(2):92–102. doi:10.1309/lmf28s2gimxnwhmm. PMID: 24868988.
   PubMedGoogle Scholar
• Liu J, Chakraborty S, Hosseinzadeh P, Yu Y, Tian S, Petrik I, Bhagi A, Lu Y. Metalloproteins containing cytochrome, iron-sulfur, or copper redox centers. Chem Rev. 2014;114(8):4366–469. doi:10.1021/cr400479b. PMID: 24758379; PMCID: PMC4002152.
   PubMed Web of Science ®Google Scholar
• Zhang C. Essential functions of iron-requiring proteins in DNA replication, repair and cell cycle control. Protein Cell. 2014;5(10):750–60. doi:10.1007/s13238-014-0083-7. Epub 2014 Jul 8. PMID: 25000876; PMCID: PMC4180463.
   PubMedGoogle Scholar
• Burmester T, Hankeln T. What is the function of neuroglobin? J Exp Biol. 2009;212(Pt 10):1423–8. doi:10.1242/jeb.000729. PMID: 19411534.
   PubMedGoogle Scholar
• Naidu AS. Lactoferrin. In: A.S. Naidu, editor. Natural food antimicrobial systems. Boca Raton (FL): CRC Press; 2000. p. 17–102. ISBN 0-8493-2047-X.
   Google Scholar
• Velasquez J, Wray AA. Deferoxamine. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021. PMID: 32491586.
   Google Scholar
• Origa R, Galanello R, Ganz T, Giagu N, Maccioni L, Faa G, Nemeth E. Liver iron concentrations and urinary hepcidin in beta-thalassemia. Haematologica. 2007;92(5):583–8. doi:10.3324/haematol.10842. PMID: 17488680.
   PubMed Web of Science ®Google Scholar
• Fleming RE, Ponka P. Iron overload in human disease. N Engl J Med. 2012;366(4):348–59. doi:10.1056/NEJMra1004967. Erratum in: N Engl J Med. 2012 Feb 23;366(8):771. PMID: 22276824.
   PubMed Web of Science ®Google Scholar
• Papanikolaou G, Pantopoulos K. Systemic iron homeostasis and erythropoiesis. IUBMB Life. 2017;69(6):399–413. doi:10.1002/iub.1629. Epub 2017 Apr 6. PMID: 28387022.
   PubMed Web of Science ®Google Scholar
• Kerins MJ, Ooi A. The roles of NRF2 in modulating cellular iron homeostasis. Antioxid Redox Signal. 2018;29(17):1756–73. doi: 10.1089/ars.2017.7176. Epub 2017 Sep 21. PMID: 28793787; PMCID: PMC6208163.
   PubMed Web of Science ®Google Scholar
• Gao G, Li J, Zhang Y, Chang YZ. Cellular iron metabolism and regulation. Adv Exp Med Biol. 2019;1173:21–32. doi:10.1007/978-981-13-9589-5_2. PMID: 31456203.
   PubMed Web of Science ®Google Scholar
• Gammella E, Buratti P, Cairo G, Recalcati S. The transferrin receptor: the cellular iron gate. Metallomics. 2017;9(10):1367–75. doi:10.1039/c7mt00143f. PMID: 28671201.
   PubMed Web of Science ®Google Scholar
• Drakesmith H, Nemeth E, Ganz T. Ironing out ferroportin. Cell Metab. 2015;22(5):777–87. doi:10.1016/j.cmet.2015.09.006. Epub 2015 Oct 1. PMID: 26437604; PMCID: PMC4635047.
   PubMed Web of Science ®Google Scholar
• Kühn LC. Iron regulatory proteins and their role in controlling iron metabolism. Metallomics. 2015;7(2):232–43. doi: 10.1039/c4mt00164h. PMID: 25306858.
   PubMed Web of Science ®Google Scholar
• Knutson MD. Iron transport proteins: Gateways of cellular and systemic iron homeostasis. J Biol Chem. 2017;292(31):12735–43. doi: 10.1074/jbc.R117.786632. Epub 2017 Jun 14. PMID: 28615441; PMCID: PMC5546014.
   PubMed Web of Science ®Google Scholar
• Ganz T. Systemic iron homeostasis. Physiol Rev. 2013;93(4):1721–41. doi: 10.1152/physrev.00008.2013. PMID: 24137020.
   PubMed Web of Science ®Google Scholar
• Ganz T, Nemeth E. Iron homeostasis in host defense and inflammation. Nat Rev Immunol. 2015;15(8):500–10. Epub 2015 Jul 10. PMID: 26160612; PMCID: PMC4801113. doi:10.1038/nri3863.
   PubMed Web of Science ®Google Scholar
• Wang CY, Babitt JL. Hepcidin regulation in the anemia of inflammation. Curr Opin Hematol. 2016;23(3):189–97. doi:10.1097/MOH.0000000000000236. PMID: 26886082; PMCID: PMC4993159.
   PubMed Web of Science ®Google Scholar
• Drakesmith H, Prentice A. Viral infection and iron metabolism. Nat Rev Microbiol. 2008;6(7):541–52. 52. doi:10.1038/nrmicro1930. PMID: 18864.
   PubMed Web of Science ®Google Scholar
• Bellotti D, Remelli M. Deferoxamine B: a natural, excellent and versatile metal chelator. Molecules. 2021;26(11):3255. PMID: 34071479; PMCID: PMC8198152. doi:10.3390/molecules26113255.
   PubMedGoogle Scholar
• Schmidt SM. The role of iron in viral infections. Front Biosci (Landmark Ed). 2020;25(5):893–911. doi:10.2741/4839. PMID: 31585922.
   PubMedGoogle Scholar
• Xiong S, She H, Takeuchi H, Han B, Engelhardt JF, Barton CH, Zandi E, Giulivi C, Tsukamoto H. Signaling role of intracellular iron in NF-kappaB activation. J Biol Chem. 2003; May 16278(20):17646–54. Epub 2003 Mar 11. PMID: 12637578. doi:10.1074/jbc.M210905200.
   PubMedGoogle Scholar
• Liu W, Zhang S, Nekhai S, Liu S. Depriving iron supply to the virus represents a promising adjuvant therapeutic against viral survival. Curr Clin Microbiol Rep. 2020;1–7. doi:10.1007/s40588-020-00140-w.Epub ahead of print. PMID: 32318324; PMCID: PMC7169647.
   PubMedGoogle Scholar
• Jones G, Goswami SK, Kang H, Choi HS, Kim J. Combating iron overload: a case for deferoxamine-based nanochelators. Nanomedicine (Lond). 2020;15(13):1341–56. Epub ahead of print. PMID: 32429801; PMCID: PMC7304435. doi:10.2217/nnm-2020-0038.
   PubMedGoogle Scholar
• Sonnweber T, Boehm A, Sahanic S, Pizzini A, Aichner M, Sonnweber B, Kurz K, Koppelstätter S, Haschka D, Petzer V, et al. Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients’ performance: a prospective observational cohort study. Respir Res. 2020;21(1):276. doi:10.1186/s12931-020-01546-2. PMID: 33087116; PMCID: PMC7575703.
   PubMed Web of Science ®Google Scholar
• Khan NA, Akhtar J. Respiratory and ventilator management of COVID-19. J Pak Med Assoc. 2020;70(Suppl 3, 5):S60–S63. doi: 10.5455/JPMA.23. PMID: 32515384.
   PubMedGoogle Scholar
• Gasmi A, Noor S, Tippairote T, Dadar M, Menzel A, Bjørklund G. Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic. Clin Immunol. 2020;215:108409. doi: 10.1016/j.clim.2020.108409. Epub 2020 Apr 7. PMID: 32276137; PMCID: PMC7139252.
   PubMed Web of Science ®Google Scholar
• Taribagil P, Creer D, Tahir H. COVID’ syndrome. BMJ Case Rep. 2021;14(4):e241485. PMID: 33875508; PMCID: PMC8057566. doi:10.1136/bcr-2020-241485.
   PubMedGoogle Scholar
• Debuc B, Smadja DM. Is COVID-19 a new hematologic disease? Stem Cell Rev Rep. 2021;17(1):4–8. doi:10.1007/s12015-020-09987-4. PMID: 32399806; PMCID: PMC7217340.
   PubMed Web of Science ®Google Scholar
• Ni W, Yang X, Yang D, Bao J, Li R, Xiao Y, Hou C, Wang H, Liu J, Yang D, et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care. 2020;24(1):422. doi:10.1186/s13054-020-03120-0. PMID: 32660650; PMCID: PMC7356137.
   PubMed Web of Science ®Google Scholar
• Aghagoli G, Gallo Marin B, Katchur NJ, Chaves-Sell F, Asaad WF, Murphy SA. Neurological involvement in COVID-19 and potential mechanisms: a review. Neurocrit Care. 2021;34(3):1062–71. doi:10.1007/s12028-020-01049-4. PMID: 32661794; PMCID: PMC7358290.
   PubMed Web of Science ®Google Scholar
• Cantuti-Castelvetri L, Ojha R, Pedro LD, Djannatian M, Franz J, Kuivanen S, van der Meer F, Kallio K, Kaya T, Anastasina M, et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. 2020;370(6518):856–60. doi:10.1126/science.abd2985. Epub 2020 Oct 20. PMID: 33082293; PMCID: PMC7857391.
   PubMed Web of Science ®Google Scholar
• Mayi BS, Leibowitz JA, Woods AT, Ammon KA, Liu AE, Raja, A,. The role of Neuropilin-1 in COVID-19. PLoS Pathog. 2021;17(1):e1009153. doi:10.1371/journal.ppat.1009153. PMID: 33395426; PMCID: PMC7781380.
   PubMed Web of Science ®Google Scholar
• Perricone C, Bartoloni E, Bursi R, Cafaro G, Guidelli GM, Shoenfeld Y, Gerli R. COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy. Immunol Res. 2020;68(4):213–24. doi:10.1007/s12026-020-09145-5. PMID: 32681497; PMCID: PMC7366458.
   PubMed Web of Science ®Google Scholar
• Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, Tan W. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020;323(18):1843–4. doi:10.1001/jama.2020.3786. PMID: 32159775; PMCID: PMC7066521.
   PubMed Web of Science ®Google Scholar
• Pearce EL, Pearce EJ. Metabolic pathways in immune cell activation and quiescence. Immunity. 2013;38(4):633–43. doi:10.1016/j.immuni.2013.04.005. PMID: 23601682; PMCID: PMC3654249.
   PubMed Web of Science ®Google Scholar
• Ferraro E, Germanò M, Mollace R, Mollace V, Malara N. HIF-1, the Warburg effect, and macrophage/microglia polarization potential role in COVID-19 pathogenesis. Oxid Med Cell Longev. 2021;2021:8841911. doi: 10.1155/2021/8841911. PMID: 33815663; PMCID: PMC7987467.
   PubMedGoogle Scholar
• Agani FH, Pichiule P, Chavez JC, LaManna JC. The role of mitochondria in the regulation of hypoxia-inducible factor 1 expression during hypoxia. J Biol Chem. 2000;275(46):35863–7. doi:10.1074/jbc.M005643200. PMID: 10961998.
   PubMedGoogle Scholar
• Nizet V, Johnson RS. Interdependence of hypoxic and innate immune responses. Nat Rev Immunol. 2009;9(9):609–17. doi:10.1038/nri2607. PMID: 19704417; PMCID: PMC4343208.
   PubMed Web of Science ®Google Scholar
• Santos SAD, Andrade DRd. HIF-1alpha and infectious diseases: a new frontier for the development of new therapies. Rev Inst Med Trop Sao Paulo. 2017;59:e92. doi:10.1590/S1678-9946201759092. PMID: 29267600; PMCID: PMC5738998.
   PubMed Web of Science ®Google Scholar
• Jahani M, Dokaneheifard S, Mansouri K. Hypoxia: a key feature of COVID-19 launching activation of HIF-1 and cytokine storm. J Inflamm. 2020;17(1):33. PMID: 33292282. doi:10.1186/s12950-020-00263-3.
   Google Scholar
• Zhang C, Wu Z, Li LW, Zhao H, Wang GQ. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. 2020 May;55(5):105954. doi:10.1016/j.ijantimicag.2020.105954. Epub 2020 Mar 29. PMID: 32234467; PMCID: PMC7118634.
   PubMed Web of Science ®Google Scholar
• Teuwen LA, Geldhof V, Pasut A, Carmeliet P. COVID-19: the vasculature unleashed. Nat Rev Immunol. 2020;20(7):389–91. doi:10.1038/s41577-020-0343-0. Erratum in: Nat Rev Immunol. 2020 Jun 4;: PMID: 32439870; PMCID: PMC7240244.
   PubMed Web of Science ®Google Scholar
• Marchetti M. COVID-19-driven endothelial damage: complement, HIF-1, and ABL2 are potential pathways of damage and targets for cure. Ann Hematol. 2020;99(8):1701–7. doi:10.1007/s00277-020-04138-8. Epub 2020 Jun 24. PMID: 32583086; PMCID: PMC7312112.
   PubMed Web of Science ®Google Scholar
• Kominsky DJ, Campbell EL, Colgan SP. Metabolic shifts in immunity and inflammation. J Immunol. 2010;184(8):4062–8. doi: 10.4049/jimmunol.0903002. PMID: 20368286; PMCID: PMC4077461.
   PubMed Web of Science ®Google Scholar
• Kelly B, O’Neill LAJ. Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res. 2015;25(7):771–84. doi: 10.1038/cr.2015.68. Epub 2015 Jun 5. PMID: 26045163; PMCID: PMC4493277.
   PubMed Web of Science ®Google Scholar
• Ryan DG, O’Neill LAJ. Krebs Cycle Reborn in Macrophage Immunometabolism. Annu Rev Immunol. 2020;38:289–313. doi:10.1146/annurev-immunol-081619-104850. Epub 2020 Jan 27. PMID: 31986069.
   PubMed Web of Science ®Google Scholar
• Mehrzadi S, Karimi MY, Fatemi A, Reiter RJ, Hosseinzadeh A. SARS-CoV-2 and other coronaviruses negatively influence mitochondrial quality control: beneficial effects of melatonin. Pharmacol Ther. 2021;224:107825. doi:10.1016/j.pharmthera.2021.107825. Epub ahead of print. PMID: 33662449; PMCID: PMC7919585.
   PubMed Web of Science ®Google Scholar
• Obach M, Navarro-Sabaté A, Caro J, Kong X, Duran J, Gómez M, Perales JC, Ventura F, Rosa JL, Bartrons R. 6-Phosphofructo-2-kinase (pfkfb3) gene promoter contains hypoxia-inducible factor-1 binding sites necessary for transactivation in response to hypoxia. J Biol Chem. 2004;279(51):53562–70. doi:10.1074/jbc.M406096200. Epub 2004 Oct 5. PMID: 15466858.
   PubMed Web of Science ®Google Scholar
• Palsson-McDermott EM, O’Neill LA. The Warburg effect then and now: from cancer to inflammatory diseases. Bioessays. 2013;35(11):965–73. doi:10.1002/bies.201300084. Epub 2013 Sep 20. PMID: 24115022.
   PubMed Web of Science ®Google Scholar
• Krawczyk CM, Holowka T, Sun J, Blagih J, Amiel E, DeBerardinis RJ, Cross JR, Jung E, Thompson CB, Jones RG, et al. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood. 2010;115(23):4742–9. doi: 10.1182/blood-2009-10-249540. Epub 2010 Mar 29. PMID: 20351312; PMCID: PMC2890190.
   PubMed Web of Science ®Google Scholar
• Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G, Frezza C, Bernard NJ, Kelly B, Foley NH, et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature. 2013;496(7444):238–42. Epub 2013 Mar 24. PMID: 23535595; PMCID: PMC4031686. doi:10.1038/nature11986.
   PubMed Web of Science ®Google Scholar
• Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD, Pan Y, Simon MC, Thompson CB, Gottlieb E. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell. 2005;7(1):77–85. doi:10.1016/j.ccr.2004.11.022. PMID: 15652751.
   PubMed Web of Science ®Google Scholar
• Nishi K, Oda T, Takabuchi S, Oda S, Fukuda K, Adachi T, Semenza GL, Shingu K, Hirota K. LPS induces hypoxia-inducible factor 1 activation in macrophage-differentiated cells in a reactive oxygen species-dependent manner. Antioxid Redox Signal. 2008;10(5):983–95. doi:10.1089/ars.2007.1825. PMID: 18199003.
   PubMedGoogle Scholar
• Mills EL, Kelly B, Logan A, Costa ASH, Varma M, Bryant CE, Tourlomousis P, Däbritz JHM, Gottlieb E, Latorre I, et al. Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages. Cell. 2016;167(2):457–70.e13. doi:10.1016/j.cell.2016.08.064. Epub 2016 Sep 22. PMID: 27667687; PMCID: PMC5863951.
   PubMed Web of Science ®Google Scholar
• Codo AC, Davanzo GG, Monteiro LB, de Souza GF, Muraro SP, Virgilio-da-Silva JV, Prodonoff JS, Carregari VC, de Biagi Junior CAO, Crunfli F, et al. Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1α/glycolysis-dependent axis. Cell Metab. 2020;32(3):437–46.e5. doi:10.1016/j.cmet.2020.07.007. Epub 2020 Jul 17. Erratum in: Cell Metab. 2020 Sep 1;32(3):498–499. PMID: 32697943; PMCID: PMC7367032.
   PubMed Web of Science ®Google Scholar
• Peng T, Du SY, Son M, Diamond B. HIF-1α is a negative regulator of interferon regulatory factors: Implications for interferon production by hypoxic monocytes. Proc Natl Acad Sci U S A. 2021;118(26):e2106017118. doi:10.1073/pnas.2106017118.PMID: 34108245; PMCID: PMC8256008.
   PubMedGoogle Scholar
• Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020;20(6):363–74. doi:10.1038/s41577-020-0311-8. Epub 2020 Apr 28. PMID: 32346093; PMCID: PMC7187672.
   PubMed Web of Science ®Google Scholar
• Zheng M, Gao Y, Wang G, Song G, Liu S, Sun D, Xu Y, Tian Z. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol. 2020;17(5):533–5. doi:10.1038/s41423-020-0402-2. Epub 2020 Mar 19. PMID: 32203188; PMCID: PMC7091858.
   PubMed Web of Science ®Google Scholar
• Williams NC, O’Neill LAJ. A role for the krebs cycle intermediate citrate in metabolic reprogramming in innate immunity and inflammation. Front Immunol. 2018;9:141. doi:10.3389/fimmu.2018.00141. PMID: 29459863; PMCID: PMC5807345.
   PubMed Web of Science ®Google Scholar
• Le Lan C, Loréal O, Cohen T, Ropert M, Glickstein H, Lainé F, Pouchard M, Deugnier Y, Le Treut A, Breuer W, et al. P. Redox active plasma iron in C282Y/C282Y hemochromatosis. Blood. 2005;105(11):4527–31. Epub 2005 Jan 25. PMID: 15671444. doi:10.1182/blood-2004-09-3468.
   PubMed Web of Science ®Google Scholar
• Bellmann-Weiler R, Lanser L, Barket R, Rangger L, Schapfl A, Schaber M, Fritsche G, Wöll E, Weiss G. Prevalence and predictive value of anemia and dysregulated iron homeostasis in patients with COVID-19 infection. JCM. 2020;9(8):2429. PMID: 32751400; PMCID: PMC7464087. doi:10.3390/jcm9082429.
   Web of Science ®Google Scholar
• Singh Y, Gupta G, Kazmi I, Al-Abbasi FA, Negi P, Chellappan DK, Dua K. SARS CoV-2 aggravates cellular metabolism mediated complications in COVID-19 infection. Dermatol Ther. 2020;33(6):e13871. doi:10.1111/dth.13871. Epub 2020 Jul 7. PMID: 32558055; PMCID: PMC7323108.
   PubMed Web of Science ®Google Scholar
• Muhoberac BB. What can cellular redox, iron, and reactive oxygen species suggest about the mechanisms and potential therapy of COVID-19? Front Cell Infect Microbiol. 2020;10:569709. doi:10.3389/fcimb.2020.569709. PMID: 33381464; PMCID: PMC7767833.
   PubMedGoogle Scholar
• Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–62. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. PMID: 32171076; PMCID: PMC7270627. doi:10.1016/S0140-6736(20)30566-3.
   PubMed Web of Science ®Google Scholar
• Cheng L, Li H, Li L, Liu C, Yan S, Chen H, Li Y. Ferritin in the coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. J Clin Lab Anal. 2020;34(10):e23618. Epub 2020 Oct 19. PMID: 33078400; PMCID: PMC7595919. doi:10.1002/jcla.23618.
   PubMed Web of Science ®Google Scholar
• Arosio P, Elia L, Poli M. Ferritin, cellular iron storage and regulation. IUBMB Life. 2017;69(6):414–22. doi:10.1002/iub.1621. Epub 2017 Mar 27. PMID: 28349628.
   PubMed Web of Science ®Google Scholar
• Koorts AM, Viljoen M. Ferritin and ferritin isoforms II: protection against uncontrolled cellular proliferation, oxidative damage and inflammatory processes. Arch Physiol Biochem. 2007;113(2):55–64. doi: 10.1080/13813450701422575. PMID: 17558604.
   PubMedGoogle Scholar
• Ji D, Zhang D, Chen Z, Xu Z, Zhao P, Zhang M, Zhang L, Cheng G, Wang Y, Yang G, et al. E. Clinical characteristics predicting progression of COVID-19. Lancet. 2020; doi:10.2139/ssrn.3539674.
   Google Scholar
• Dahan S, Segal G, Katz I, Hellou T, Tietel M, Bryk G, Amital H, Shoenfeld Y, Dagan A. Ferritin as a marker of severity in COVID-19 patients: a fatal correlation. Isr Med Assoc J. 2020;22(8):494–500. PMID: 33236582.
   PubMed Web of Science ®Google Scholar
• Sabaka P, Koščálová A, Straka I, Hodosy J, Lipták R, Kmotorková B, Kachlíková M, Kušnírová A. Role of interleukin 6 as a predictive factor for a severe course of Covid-19: retrospective data analysis of patients from a long-term care facility during Covid-19 outbreak. BMC Infect Dis. 2021;21(1):308. doi:10.1186/s12879-021-05945-8. PMID: 33781216; PMCID: PMC8006112.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Cai T, Fan L, Lou K, Hua X, Huang Z, Gao G. Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019. Int J Infect Dis. 2020;95:332–9. doi:10.1016/j.ijid.2020.04.041. Epub 2020 Apr 22. PMID: 32334118; PMCID: PMC7195003.
   PubMed Web of Science ®Google Scholar
• Ye Q, Wang B, Mao J. The pathogenesis and treatment of the ‘Cytokine Storm’ in COVID-19. J Infect. 2020;80(6):607–13. doi:10.1016/j.jinf.2020.03.037. Epub 2020 Apr 10. PMID: 32283152; PMCID: PMC7194613.
   PubMed Web of Science ®Google Scholar
• Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, HLH Across Speciality Collaboration, UK HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–4. Epub 2020 Mar 16. PMID: 32192578; PMCID: PMC7270045. doi:10.1016/S0140-6736(20)30628-0.
   PubMed Web of Science ®Google Scholar
• Schulman S, Hu Y, Konstantinides S. Venous thromboembolism in COVID-19. Thromb Haemost. 2020;120(12):1642–53. doi:10.1055/s-0040-1718532. Epub 2020 Oct 24. PMID: 33099284; PMCID: PMC7869046.
   PubMed Web of Science ®Google Scholar
• Torti FM, Torti SV. Regulation of ferritin genes and protein. Blood. 2002;99(10):3505–16. doi:10.1182/blood.v99.10.3505. PMID: 11986201.
   PubMed Web of Science ®Google Scholar
• Ruan Q, Yang K, Wang W, Jiang L, Song J. Correction to: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(6):1294–7. doi:10.1007/s00134-020-06028-z. Erratum for: Intensive Care Med. 2020 May;46(5):846-848. PMID: 32253449; PMCID: PMC7131986.
   PubMed Web of Science ®Google Scholar
• Ehsani S. COVID-19 and iron dysregulation: distant sequence similarity between hepcidin and the novel coronavirus spike glycoprotein. Biol Direct. 2020;15(1):19. doi:10.1186/s13062-020-00275-2. PMID: 33066821; PMCID: PMC7563913.
   PubMed Web of Science ®Google Scholar
• Hirschhorn T, Stockwell BR. The development of the concept of ferroptosis. Free Radic Biol Med. 2019;133:130–43. doi: 10.1016/j.freeradbiomed.2018.09.043. Epub 2018 Sep 28. PMID: 30268886; PMCID: PMC6368883.
   PubMed Web of Science ®Google Scholar
• Li JY, Yao YM, Tian YP. Ferroptosis: a trigger of proinflammatory state progression to immunogenicity in necroinflammatory disease. Front Immunol. 2021;12:701163. doi:10.3389/fimmu.2021.701163. PMID: 34489948; PMCID: PMC8418153.
   PubMed Web of Science ®Google Scholar
• Seibt TM, Proneth B, Conrad M. Role of GPX4 in ferroptosis and its pharmacological implication. Free Radic Biol Med. 2019;133:144–52. doi:10.1016/j.freeradbiomed.2018.09.014. Epub 2018 Sep 13. PMID: 30219704.
   PubMed Web of Science ®Google Scholar
• Matsushita M, Freigang S, Schneider C, Conrad M, Bornkamm GW, Kopf M. T cell lipid peroxidation induces ferroptosis and prevents immunity to infection. J Exp Med. 2015;212(4):555–68. doi:10.1084/jem.20140857. Epub 2015 Mar 30. PMID: 25824823; PMCID: PMC4387287.
   PubMed Web of Science ®Google Scholar
• Kwon MY, Park E, Lee SJ, Chung SW. Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death. Oncotarget. 2015;6(27):24393–403. doi: 10.18632/oncotarget.5162. PMID: 26405158; PMCID: PMC4695193.
   PubMedGoogle Scholar
• Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844–7. Epub 2020 Mar 13. PMID: 32073213; PMCID: PMC7166509. doi:10.1111/jth.14768.
   PubMed Web of Science ®Google Scholar
• Gao M, Monian P, Quadri N, Ramasamy R, Jiang X. Glutaminolysis and transferrin regulate ferroptosis. Mol Cell. 2015;59(2):298–308. doi: 10.1016/j.molcel.2015.06.011. Epub 2015 Jul 9. PMID: 26166707; PMCID: PMC4506736.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu Y, Liu J, Kang R, Tang D. NEDD4L-mediated LTF protein degradation limits ferroptosis. Biochem Biophys Res Commun. 2020;531(4):581–7. doi:10.1016/j.bbrc.2020.07.032. Epub 2020 Aug 16. PMID: 32811647.
   PubMed Web of Science ®Google Scholar
• Jacobs W, Lammens M, Kerckhofs A, Voets E, Van San E, Van Coillie S, Peleman C, Mergeay M, Sirimsi S, Matheeussen V, et al. Fatal lymphocytic cardiac damage in coronavirus disease 2019 (COVID-19): autopsy reveals a ferroptosis signature. ESC Heart Fail. 2020;7(6):3772–81. Epub ahead of print. PMID: 32959998; PMCID: PMC7607145. doi:10.1002/ehf2.12958.
   PubMed Web of Science ®Google Scholar
• Yang M, Lai CL. SARS-CoV-2 infection: can ferroptosis be a potential treatment target for multiple organ involvement? Cell Death Discov. 2020;6:130. doi:10.1038/s41420-020-00369-w. PMID: 33251029; PMCID: PMC7687212.
   PubMed Web of Science ®Google Scholar
• Chen Z, Jiang J, Fu N, Chen L. Targetting ferroptosis for blood cell-related diseases. J Drug Target. 2021; Aug 31::1–15. doi:10.1080/1061186X.2021.1971237.Epub ahead of print. PMID: 34415804.
   Web of Science ®Google Scholar
• Melo AKG, Milby KM, Caparroz ALMA, Pinto ACPN, Santos RRP, Rocha AP, Ferreira GA, Souza VA, Valadares LDA, Vieira RMRA, et al. Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: A living systematic review and meta-analysis. PLoS One. 2021;16(6):e0253894. doi:10.1371/journal.pone.0253894. PMID: 34185801; PMCID: PMC8241122.
   PubMed Web of Science ®Google Scholar
• Deng F, Zhang L, Lyu L, Lu Z, Gao D, Ma X, Guo Y, Wang R, Gong S, Jiang W. Increased levels of ferritin on admission predicts intensive care unit mortality in patients with COVID-19. Med Clin (Engl Ed). 2021;156(7):324–31. Epub 2021 Apr 1. PMID: 33824908; PMCID: PMC8016043. doi:10.1016/j.medcle.2020.11.015.
   PubMedGoogle Scholar
• Bergamaschi G, Borrelli de Andreis F, Aronico N, Lenti MV, Barteselli C, Merli S, Pellegrino I, Coppola L, Cremonte EM, Croce G, Internal Medicine Covid-19 Collaborators, et al. Internal medicine Covid-19 collaborators. Anemia in patients with Covid-19: pathogenesis and clinical significance. Clin Exp Med. 2021;21(2):239–46. doi:10.1007/s10238-020-00679-4. Epub 2021 Jan 8. Erratum in: Clin Exp Med. 2021 Mar 17;: PMID: 33417082; PMCID: PMC7790728.
   PubMed Web of Science ®Google Scholar
• Sun DW, Zhang D, Tian RH, Li Y, Wang YS, Cao J, Tang Y, Zhang N, Zan T, Gao L, et al. The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: A sentinel? Clin Chim Acta. 2020;508:122–9. doi:10.1016/j.cca.2020.05.027. Epub 2020 May 14. PMID: 32417210; PMCID: PMC7224669.
   PubMed Web of Science ®Google Scholar
• Wessling-Resnick M. Crossing the iron gate: why and how transferrin receptors mediate viral entry. Annu Rev Nutr. 2018;38:431–58. doi:10.1146/annurev-nutr-082117-051749. Epub 2018 May 31. PMID: 29852086; PMCID: PMC6743070.
   PubMed Web of Science ®Google Scholar
• Weiss RJ, Esko JD, Tor Y. Targeting heparin and heparan sulfate protein interactions. Org Biomol Chem. 2017;15(27):5656–68. doi:10.1039/c7ob01058c. Epub 2017 Jun 27. PMID: 28653068; PMCID: PMC5567684.
   PubMed Web of Science ®Google Scholar
• Fan BE, Chong VCL, Chan SSW, Lim GH, Lim KGE, Tan GB, Mucheli SS, Kuperan P, Ong KH. Hematologic parameters in patients with COVID-19 infection. Am J Hematol. 2020;95(6):E131–E134. doi:10.1002/ajh.25774. Epub 2020 Mar 19. Erratum in: Am J Hematol. 2020 Nov;95(11):1442. PMID: 32129508.
   PubMed Web of Science ®Google Scholar
• Su WL, Lin CP, Hang HC, Wu PS, Cheng CF, Chao YC. Desaturation and heme elevation during COVID-19 infection: a potential prognostic factor of heme oxygenase-1. J Microbiol Immunol Infect. 2021;54(1):113–6. doi:10.1016/j.jmii.2020.10.001. Epub 2020 Oct 16. PMID: 33176981; PMCID: PMC7566820.
   PubMedGoogle Scholar
• Taneri PE, Gómez-Ochoa SA, Llanaj E, Raguindin PF, Rojas LZ, Roa-Díaz ZM, Salvador D, Jr, Groothof D, Minder B, Kopp-Heim D, et al. Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis. Eur J Epidemiol. 2020;35(8):763–73. doi:10.1007/s10654-020-00678-5. Epub 2020 Aug 20. PMID: 32816244; PMCID: PMC7438401.
   PubMed Web of Science ®Google Scholar
• Wagener F, Pickkers P, Peterson SJ, Immenschuh S, Abraham NG. Targeting the heme-heme oxygenase system to prevent severe complications following COVID-19 infections. 19. Antioxidants (Basel). 2020;9(6):540. PMID: 32575554; PMCID: PMC7346191. doi:10.3390/antiox9060540.
   PubMedGoogle Scholar
• Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417–8. Epub 2020 Apr 21. PMID: 32325026; PMCID: PMC7172722. doi:10.1016/S0140-6736(20)30937-5.
   PubMed Web of Science ®Google Scholar
• Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5):1094–9. doi:10.1111/jth.14817. Epub 2020 Apr 27. PMID: 32220112.
   PubMed Web of Science ®Google Scholar
• Jankun J, Landeta P, Pretorius E, Skrzypczak-Jankun E, Lipinski B. Unusual clotting dynamics of plasma supplemented with iron(III). Int J Mol Med. 2014 Feb;33(2):367–72. doi:10.3892/ijmm.2013.1585. Epub 2013 Dec 11. PMID: 24337469.
   PubMedGoogle Scholar
• Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020 May 2;395(10234):1417–1418. doi:10.1016/S0140-6736(20)30937-5. Epub 2020 Apr 21. PMID: 32325026; PMCID: PMC7172722.
   PubMed Web of Science ®Google Scholar
• Shahbaz S, Xu L, Osman M, Sligl W, Shields J, Joyce M, Tyrrell DL, Oyegbami O, Elahi S. Erythroid precursors and progenitors suppress adaptive immunity and get invaded by SARS-CoV-2. Stem Cell Reports. 2021;16(5):1165–81. doi:10.1016/j.stemcr.2021.04.001. PMID: 33979601; PMCID: PMC8111797.
   PubMedGoogle Scholar
• Kronstein-Wiedemann R, Stadtmüller M, Traikov S, Georgi M, Teichert M, Yosef H, Wallenborn J, Karl A, Schütze K, Wagner M, et al. SARS-CoV-2 infects red blood cell progenitors and dysregulates hemoglobin and iron metabolism. Stem Cell Rev Rep. 2022;18:1–13. doi:10.1007/s12015-021-10322-8.Epub ahead of print. PMID: 35181867; PMCID: PMC8856880.
   PubMedGoogle Scholar
• Huerga Encabo H, Grey W, Garcia-Albornoz M, Wood H, Ulferts R, Aramburu IV, Kulasekararaj AG, Mufti G, Papayannopoulos V, Beale R, et al. Human erythroid progenitors are directly infected by SARS-CoV-2: Implications for emerging erythropoiesis in severe COVID-19 patients. Stem Cell Reports. 2021;16(3):428–36. doi: 10.1016/j.stemcr.2021.02.001. Epub 2021 Feb 5. PMID: 33581053; PMCID: PMC7862909.
   PubMedGoogle Scholar
• Balzanelli MG, Distratis P, Dipalma G, Vimercati L, Inchingolo AD, Lazzaro R, Aityan SK, Maggiore ME, Mancini A, Laforgia R, et al. Sars-CoV-2 Virus Infection May Interfere CD34+ Hematopoietic Stem Cells and Megakaryocyte-Erythroid Progenitors Differentiation Contributing to Platelet Defection towards Insurgence of Thrombocytopenia and Thrombophilia. Microorganisms. 2021;9(8):1632. PMID: 34442710; PMCID: PMC8400074. doi:10.3390/microorganisms9081632.
   PubMedGoogle Scholar
• Rapozzi V, Juarranz A, Habib A, Ihan A, Strgar R. Is HAEM the real target of COVID-19? Photodiagnosis Photodyn Ther. 2021;35:102381. doi:10.1016/j.pdpdt.2021.102381. Epub 2021 Jun 11. PMID: 34119708; PMCID: PMC8192263.
   PubMedGoogle Scholar
• Conti P, Younes A. Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection. J Biol Regul Homeost Agents. 2020;34(2):339–43. doi:10.23812/Editorial-Conti-3. PMID: 32253888.
   PubMed Web of Science ®Google Scholar
• Jin JM, Bai P, He W, Wu F, Liu XF, Han DM, Liu S, Yang JK. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health. 2020;8:152. doi:10.3389/fpubh.2020.00152. PMID: 32411652; PMCID: PMC7201103.
   PubMed Web of Science ®Google Scholar
• Naidu SAG, Clemens RA, Pressman P, Zaigham M, Kadkhoda K, Davies KJA, Naidu AS. COVID-19 during pregnancy and postpartum. I) Pathobiology of severe acute respiratory syndrome coronavirus-2 (SARSCoV-2) at maternal-fetal interface. J Diet Suppl. 2022;19(1):115–42. doi:10.1080/19390211.2020.1834049. Epub 2020 Nov 8. PMID: 33164601.
   PubMedGoogle Scholar
• Sankaran VG, Orkin SH. The switch from fetal to adult hemoglobin. Cold Spring Harb Perspect Med. 2013;3(1):a011643. doi:10.1101/cshperspect.a011643. PMID: 23209159; PMCID: PMC3530042.
   PubMed Web of Science ®Google Scholar
• Drouin E. Beta-thalassemia may protect against COVID 19. Med Hypotheses. 2020;143:110014. doi:10.1016/j.mehy.2020.110014. Epub 2020 Jun 28. PMID: 32615501; PMCID: PMC7321655.
   PubMed Web of Science ®Google Scholar
• Motta I, Migone De Amicis M, Pinto VM, Balocco M, Longo F, Bonetti F, Gianesin B, Graziadei G, Cappellini MD, De Franceschi L, et al. SARS-CoV-2 infection in beta thalassemia: preliminary data from the Italian experience. Am J Hematol. 2020;95(8):E198–E199. doi:10.1002/ajh.25840. Epub 2020 May 6. PMID: 32311145; PMCID: PMC7264660.
   PubMed Web of Science ®Google Scholar
• Wenzhong L, Hualan L. COVID-19: captures iron and generates reactive oxygen species to damage the human immune system. Autoimmunity. 2021;54(4):213–2. Epub ahead of print. PMID: 33899609; PMCID: PMC8074649. doi:10.1080/08916934.2021.1913581.
   PubMed Web of Science ®Google Scholar
• Lechuga GC, Souza-Silva F, Sacramento CQ, Trugilho MRO, Valente RH, Napoleão-Pêgo P, Dias SSG, Fintelman-Rodrigues N, Temerozo JR, Carels N, et al. SARS-CoV-2 proteins bind to hemoglobin and its metabolites. IJMS. 2021;22(16):9035. PMID: 34445741; PMCID: PMC8396565. doi:10.3390/ijms22169035.
   Google Scholar
• Ulrich H, Pillat MM. CD147 as a target for COVID-19 treatment: suggested effects of azithromycin and stem cell engagement. Stem Cell Rev Rep. 2020;16(3):434–40. doi:10.1007/s12015-020-09976-7. PMID: 32307653; PMCID: PMC7167302.
   PubMed Web of Science ®Google Scholar
• Radzikowska U, Ding M, Tan G, Zhakparov D, Peng Y, Wawrzyniak P, Wang M, Li S, Morita H, Altunbulakli C, et al. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy. 2020;75(11):2829–45. doi:10.1111/all.14429. Epub 2020 Aug 24. PMID: 32496587; PMCID: PMC7300910.
   PubMed Web of Science ®Google Scholar
• Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers D, Kant KM, Kaptein FHJ, van Paassen J, Stals MAM, Huisman MV, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145–7. doi:10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10. PMID: 32291094; PMCID: PMC7146714.
   PubMed Web of Science ®Google Scholar
• Manne BK, Denorme F, Middleton EA, Portier I, Rowley JW, Stubben C, Petrey AC, Tolley ND, Guo L, Cody M, et al. Platelet gene expression and function in patients with COVID-19. Blood. 2020;136(11):1317–29. doi:10.1182/blood.2020007214. PMID: 32573711; PMCID: PMC7483430.
   PubMed Web of Science ®Google Scholar
• Barnes BJ, Adrover JM, Baxter-Stoltzfus A, Borczuk A, Cools-Lartigue J, Crawford JM, Daßler-Plenker J, Guerci P, Huynh C, Knight JS, et al. Targeting potential drivers of COVID-19: Neutrophil extracellular traps. J Exp Med. 2020;217(6):e20200652. doi:10.1084/jem.20200652.PMID: 32302401; PMCID: PMC7161085.
   PubMed Web of Science ®Google Scholar
• Middleton EA, He XY, Denorme F, Campbell RA, Ng D, Salvatore SP, Mostyka M, Baxter-Stoltzfus A, Borczuk AC, Loda M, et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood. 2020;136(10):1169–79. PMID: 32597954; PMCID: PMC7472714. doi:10.1182/blood.2020007008.
   PubMed Web of Science ®Google Scholar
• Twaddell SH, Baines KJ, Grainge C, Gibson PG. The Emerging Role of Neutrophil Extracellular Traps in Respiratory Disease. Chest. 2019;156(4):774–82. doi:10.1016/j.chest.2019.06.012. Epub 2019 Jun 29. PMID: 31265835.
   PubMed Web of Science ®Google Scholar
• Zuo Y, Yalavarthi S, Shi H, Gockman K, Zuo M, Madison JA, Blair C, Weber A, Barnes BJ, Egeblad M, et al. Neutrophil extracellular traps in COVID-19. JCI Insight. 2020;5(11):e138999. PMID: 32329756; PMCID: PMC7308057. doi:10.1172/jci.insight.138999.
   PubMed Web of Science ®Google Scholar
• Fuchs TA, Abed U, Goosmann C, Hurwitz R, Schulze I, Wahn V, Weinrauch Y, Brinkmann V, Zychlinsky A. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol. 2007;176(2):231–41. doi: 10.1083/jcb.200606027. Epub 2007 Jan 8. PMID: 17210947; PMCID: PMC2063942.
   PubMed Web of Science ®Google Scholar
• Muraro SP, De Souza GF, Gallo SW, Da Silva BK, De Oliveira SD, Vinolo MAR, Saraiva EM, Porto BN. Respiratory syncytial virus induces the classical ROS-dependent netosis through pad-4 and necroptosis pathways activation. Sci Rep. 2018;8(1):14166. doi:10.1038/s41598-018-32576-y. PMID: 30242250; PMCID: PMC6154957.
   PubMedGoogle Scholar
• Vorobjeva NV, Chernyak BV. NETosis: molecular mechanisms, role in physiology and pathology. Biochemistry (Mosc). 2020;85(10):1178–90. doi:10.1134/S0006297920100065. PMID: 33202203; PMCID: PMC7590568.
   PubMed Web of Science ®Google Scholar
• Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Zhong NS, et al. China medical treatment expert Group for Covid-19. clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20. Epub 2020 Feb 28. PMID: 32109013; PMCID: PMC7092819. doi:10.1056/NEJMoa2002032.
   PubMed Web of Science ®Google Scholar
• Arcanjo A, Logullo J, Menezes CCB, de Souza Carvalho Giangiarulo TC, Dos Reis MC, de Castro GMM, da Silva Fontes Y, Todeschini AR, Freire-de-Lima L, Decoté-Ricardo D, et al. The emerging role of neutrophil extracellular traps in severe acute respiratory syndrome coronavirus 2 (COVID-19). Sci Rep. 2020;10(1):19630. doi:10.1038/s41598-020-76781-0. PMID: 33184506; PMCID: PMC7665044.
   PubMed Web of Science ®Google Scholar
• Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135(23):2033–40. doi:10.1182/blood.2020006000. PMID: 32339221; PMCID: PMC7273827.
   PubMed Web of Science ®Google Scholar
• Zuo Y, Zuo M, Yalavarthi S, Gockman K, Madison JA, Shi H, Woodard W, Lezak SP, Lugogo NL, Knight JS, et al. Neutrophil extracellular traps and thrombosis in COVID-19. medRxiv [Preprint]. 2020; May 5:2020.04.30.20086736. doi:10.1101/2020.04.30.20086736.Update in: JCI Insight. 2020 Jun 4;5(11): PMID: 32511553; PMCID: PMC7274234.
   Google Scholar
• World Health Organization. WHO director-general’s opening remarks at the media briefing on COVID-19. 2020. March 11. World Health Organization. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-atthe-media-briefing-on-Covid-19–-11-march-2020. 2020.
   Google Scholar
• Yağcı S, Serin E, Acicbe Ö, Zeren Mİ, Odabaşı MS. The relationship between serum erythropoietin, hepcidin, and haptoglobin levels with disease severity and other biochemical values in patients with COVID-19. Int J Lab Hematol. 2021;43(S1):142–51. Epub 2021 Feb 7. PMID: 33554466; PMCID: PMC8014125. doi:10.1111/ijlh.13479.
   PubMedGoogle Scholar
• Lanser L, Burkert FR, Bellmann-Weiler R, Schroll A, Wildner S, Fritsche G, Weiss G. Dynamics in anemia development and dysregulation of iron homeostasis in hospitalized patients with COVID-19. Metabolites. 2021;11(10):653. PMID: 34677368; PMCID: PMC8540370. doi:10.3390/metabo11100653.
   PubMedGoogle Scholar
• Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. WHO clinical case definition working group on post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2021;Dec(21) S1473-3099(21)007039. doi:10.1016/S1473-3099(21)00703-9.Epub ahead of print. PMID: 34951953; PMCID: PMC8691845.
   Google Scholar
• Campione E, Cosio T, Rosa L, Lanna C, Di Girolamo S, Gaziano R, Valenti P, Bianchi L. Lactoferrin as protective natural barrier of respiratory and intestinal mucosa against coronavirus infection and inflammation. Int. IJMS. 2020;21(14):4903. PMID: 32664543; PMCID: PMC7402319. doi:10.3390/ijms21144903.
   Google Scholar
• Chang R, Ng TB, Sun WZ. Lactoferrin as potential preventative and adjunct treatment for COVID-19. Int J Antimicrob Agents. 2020;56(3):106118. doi:10.1016/j.ijantimicag.2020.106118. Epub 2020 Jul 30. PMID: 32738305; PMCID: PMC7390755.
   PubMed Web of Science ®Google Scholar
• Naidu SAG, Clemens RA, Pressman P, Zaigham M, Davies KJA, Naidu AS. COVID-19 during pregnancy and postpartum. II) Antiviral spectrum of maternal lactoferrin in fetal and neonatal defense. J Diet Suppl. 2022;19(1):78–114. doi:10.1080/19390211.2020.1834047. Epub 2020 Nov 8. PMID: 33164606.
   PubMedGoogle Scholar
• Casey K, Iteen A, Nicolini R, Auten J. COVID-19 pneumonia with hemoptysis: acute segmental pulmonary emboli associated with novel coronavirus infection. Am J Emerg Med. 2020;38(7):1544.e1–e3. doi:10.1016/j.ajem.2020.04.011. Epub 2020 Apr 8. PMID: 32312574; PMCID: PMC7141630.
   PubMed Web of Science ®Google Scholar
• Higdon AN, Benavides GA, Chacko BK, Ouyang X, Johnson MS, Landar A, Zhang J, Darley-Usmar VM. Hemin causes mitochondrial dysfunction in endothelial cells through promoting lipid peroxidation: the protective role of autophagy. Am J Physiol Heart Circ Physiol. 2012;302(7):H1394–409. doi: 10.1152/ajpheart.00584.2011. Epub 2012 Jan 13. PMID: 22245770; PMCID: PMC3330785.
   PubMedGoogle Scholar
• Wegiel B, Hauser CJ, Otterbein LE. Heme as a danger molecule in pathogen recognition. Free Radic Biol Med. 2015;89:651–61. doi:10.1016/j.freeradbiomed.2015.08.020. Epub 2015 Oct 9. PMID: 26456060.
   PubMedGoogle Scholar
• Immenschuh S, Vijayan V, Janciauskiene S, Gueler F. Heme as a target for therapeutic interventions. Front Pharmacol. 2017;8:146. doi: 10.3389/fphar.2017.00146. PMID: 28420988; PMCID: PMC5378770.
   PubMed Web of Science ®Google Scholar
• Espinoza JA, González PA, Kalergis AM. Modulation of antiviral immunity by heme oxygenase-1. Am J Pathol. 2017;187(3):487–93. doi:10.1016/j.ajpath.2016.11.011. Epub 2017 Jan 9. PMID: 28082120.
   PubMed Web of Science ®Google Scholar
• Hooper PL. COVID-19 and heme oxygenase: novel insight into the disease and potential therapies. Cell Stress Chaperones. 2020;25(5):707–10. doi:10.1007/s12192-020-01126-9. Epub 2020 Jun 4. Erratum in: Cell Stress Chaperones. 2020 Jun 29;: PMID: 32500379; PMCID: PMC7271958.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang P, Wang H, Luo Y, Wan L, Jiang M, Chu Y. Lactoferrin for the treatment of COVID-19 (Review). Exp Ther Med. 2020;20(6):272. doi:10.3892/etm.2020.9402. Epub 2020 Oct 27. PMID: 33199997; PMCID: PMC7664603.
   PubMed Web of Science ®Google Scholar
• Rosa L, Cutone A, Lepanto MS, Paesano R, Valenti P. Lactoferrin: A Natural Glycoprotein Involved in Iron and Inflammatory Homeostasis. IJMS. 2017;18(9):1985. PMID: 28914813; PMCID: PMC5618634. doi:10.3390/ijms18091985.
   Google Scholar
• Klebanoff SJ, Waltersdorph AM. Prooxidant activity of transferrin and lactoferrin. J Exp Med. 1990;172(5):1293–303. doi: 10.1084/jem.172.5.1293. PMID: 2230644; PMCID: PMC2188654.
   PubMed Web of Science ®Google Scholar
• Roos G, Messens J. Protein sulfenic acid formation: from cellular damage to redox regulation. Free Radic Biol Med. 2011;51(2):314–26. doi:10.1016/j.freeradbiomed.2011.04.031. Epub 2011 Apr 23. PMID: 21605662.
   PubMedGoogle Scholar
• Sies H. Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: Oxidative eustress. Redox Biol. 2017;11:613–9. doi:10.1016/j.redox.2016.12.035. Epub 2017 Jan 5. PMID: 28110218; PMCID: PMC5256672.
   PubMed Web of Science ®Google Scholar
• Jegasothy H, Weerakkody R, Selby-Pham S, Bennett LE. In vitro heme and non-heme iron capture from hemoglobin, myoglobin and ferritin by bovine lactoferrin and implications for suppression of reactive oxygen species in vivo. Biometals. 2014;27(6):1371–82. doi: 10.1007/s10534-014-9798-4. Epub 2014 Oct 4. PMID: 25280951.
   PubMedGoogle Scholar
• Maneva A, Taleva B, Maneva L. Lactoferrin-protector against oxidative stress and regulator of glycolysis in human erythrocytes. Z Naturforsch C J Biosci. 2003;58(3-4):256–62. doi:10.1515/znc-2003-3-420. PMID: 12710738.
   PubMedGoogle Scholar
• Guillén C, McInnes IB, Kruger H, Brock JH. Iron, lactoferrin and iron regulatory protein activity in the synovium; relative importance of iron loading and the inflammatory response. Ann Rheum Dis. 1998;57(5):309–14. PMID: 9741316; PMCID: PMC1752600. doi:10.1136/ard.57.5.309.
   PubMedGoogle Scholar
• Volden J, Jørgensen CE, Rukke EO, Egelandsdal B. Oxidative properties of lactoferrins of different iron-saturation in an emulsion consisting of metmyoglobin and cod liver oil. Food Chem. 2012;132(3):1236–43. Epub 2011 Nov 25. PMID: 29243606. doi:10.1016/j.foodchem.2011.11.092.
   PubMed Web of Science ®Google Scholar
• Bharadwaj S, Naidu TA, Betageri GV, Prasadarao NV, Naidu AS. Inflammatory responses improve with milk ribonuclease-enriched lactoferrin supplementation in postmenopausal women. Inflamm Res. 2010;59(11):971–8. doi:10.1007/s00011-010-0211-7. Epub 2010 May 15. PMID: 20473630.
   PubMedGoogle Scholar
• Campione E, Lanna C, Cosio T, Rosa L, Conte MP, Iacovelli F, Romeo A, Falconi M, Del Vecchio C, Franchin E, et al. Lactoferrin against SARS-CoV-2: In vitro and in silico evidences. Front Pharmacol. 2021;12:666600. doi:10.3389/fphar.2021.666600. PMID: 34220505; PMCID: PMC8242182.
   PubMedGoogle Scholar
• Hu Y, Meng X, Zhang F, Xiang Y, Wang J. The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor. Emerg Microbes Infect. 2021;10(1):317–30. doi: 10.1080/22221751.2021.1888660. PMID: 33560940; PMCID: PMC7919907.
   PubMed Web of Science ®Google Scholar
• Serrano G, Kochergina I, Albors A, Diaz E, Oroval M, Hueso G. Liposomal lactoferrin as potential prevention and cure for COVID-19. Int J Res Health Sci. 2020;8:8–15. doi:10.5530/ijrhs.8.1.3.
   Google Scholar
• Lang GJ, Zhao H. Can SARS-CoV-2-infected women breastfeed after viral clearance? J Zhejiang Univ Sci B. 2020;21(5):405–7. doi: 10.1631/jzus.B2000095. Epub 2020 May 8. PMID: 32425007; PMCID: PMC7205600.
   PubMed Web of Science ®Google Scholar
• Lang J, Yang N, Deng J, Liu K, Yang P, Zhang G, Jiang C. Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans. PLoS One. 2011;6(8):e23710. doi: 10.1371/journal.pone.0023710. Epub 2011 Aug 22. PMID: 21887302; PMCID: PMC3161750.
   PubMed Web of Science ®Google Scholar
• Pietrantoni A, Di Biase AM, Tinari A, Marchetti M, Valenti P, Seganti L, Superti F. Bovine lactoferrin inhibits adenovirus infection by interacting with viral structural polypeptides. Antimicrob Agents Chemother. 2003;47(8):2688–91. doi:10.1128/AAC.47.8.2688-2691.2003. PMID: 12878543; PMCID: PMC166106.
   PubMed Web of Science ®Google Scholar
• Marr AK, Jenssen H, Moniri MR, Hancock RE, Panté N. Bovine lactoferrin and lactoferricin interfere with intracellular trafficking of Herpes simplex virus-1. Biochimie. 2009;91(1):160–4. doi:10.1016/j.biochi.2008.05.016. Epub 2008 Jun 5. PMID: 18573311.
   PubMed Web of Science ®Google Scholar
• Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat Med. 2020;26(4):450–‐2. doi:10.1038/s41591-020-0820-9. PMID: 32284615.
   PubMed Web of Science ®Google Scholar
• Nao N, Yamagishi J, Miyamoto H, Igarashi M, Manzoor R, Ohnuma A, Tsuda Y, Furuyama W, Shigeno A, Kajihara M, et al. Genetic predisposition to acquire a polybasic cleavage site for highly pathogenic avian influenza virus hemagglutinin. mBio. 2017;8(1):e02298–16. Published 2017 Feb 14. PMID: 28196963. doi:10.1128/mBio.02298-16.
   PubMed Web of Science ®Google Scholar
• van Berkel PH, Geerts ME, van Veen HA, Mericskay M, de Boer HA, Nuijens JH. N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA. Biochem J. 1997;328(1):145–‐51. PMID: 9359845 doi:10.1042/bj3280145.
   PubMedGoogle Scholar
• Kawasaki Y, Sato K, Shinmoto H, Dosako S. Role of basic residues of human lactoferrin in the interaction with B lymphocytes. Biosci Biotechnol Biochem. 2000;64(2):314–‐8. doi: 10.1271/bbb.64.314 PMID: 10737187.
   PubMed Web of Science ®Google Scholar
• Legrand D. Overview of lactoferrin as a natural immune Modulator. J Pediatr. 2016;173 Suppl(Suppl):S10–S5. doi:10.1016/j.jpeds.2016.02.071. PMID: 27234406.
   PubMedGoogle Scholar
• van der Does AM, Hensbergen PJ, Bogaards SJ, Cansoy M, Deelder AM, van Leeuwen HC, Drijfhout JW, van Dissel JT, Nibbering PH. The human lactoferrin-derived peptide hLF1-11 exerts immunomodulatory effects by specific inhibition of myeloperoxidase activity. J Immunol. 2012;188(10):5012–‐9. doi:10.4049/jimmunol.1102777. PMID: 22523385
   PubMed Web of Science ®Google Scholar
• Hendrixson DR, Qiu J, Shewry SC, Fink DL, Petty S, Baker EN, Plaut AG, St Geme JW. Human milk lactoferrin is a serine protease that cleaves Haemophilus surface proteins at arginine-rich sites. Mol Microbiol. 2003;47(3):607–‐17. doi: 10.1046/j.1365-2958.2003.03327.x PMID: 12535064.
   PubMedGoogle Scholar
• Zimecki M, Actor JK, Kruzel ML. The potential for Lactoferrin to reduce SARS-CoV-2 induced cytokine storm. Int Immunopharmacol. 2021;95:107571. doi:10.1016/j.intimp.2021.107571. Epub 2021 Mar 12. PMID: 33765614; PMCID: PMC7953442.
   PubMedGoogle Scholar
• Paesano R, Pietropaoli M, Gessani S, Valenti P. The influence of lactoferrin, orally administered, on systemic iron homeostasis in pregnant women suffering of iron deficiency and iron deficiency anaemia. Biochimie. 2009;91(1):44–51. doi:10.1016/j.biochi.2008.06.004. Epub 2008 Jun 14. PMID: 18601971.
   PubMed Web of Science ®Google Scholar
• Cutone A, Rosa L, Lepanto MS, Scotti MJ, Berlutti F, Bonaccorsi di Patti MC, Musci G, Valenti P. Lactoferrin efficiently counteracts the inflammation-induced changes of the iron homeostasis system in macrophages. Front Immunol. 2017;8:705. doi:10.3389/fimmu.2017.00705. PMID: 28663751; PMCID: PMC5471297.
   PubMed Web of Science ®Google Scholar
• Zwirzitz A, Reiter M, Skrabana R, Ohradanova-Repic A, Majdic O, Gutekova M, Cehlar O, Petrovčíková E, Kutejova E, Stanek G, et al. Lactoferrin is a natural inhibitor of plasminogen activation. J Biol Chem. 2018;293(22):8600–13. doi:10.1074/jbc.RA118.003145. Epub 2018 Apr 18. PMID: 29669808; PMCID: PMC5986228.
   PubMedGoogle Scholar
• Marietta M, Coluccio V, Luppi M. COVID-19, coagulopathy and venous thromboembolism: more questions than answers. Intern Emerg Med. 2020;15(8):1375–87. doi:10.1007/s11739-020-02432-x. Epub 2020 Jul 11. PMID: 32653981; PMCID: PMC7352087.
   PubMed Web of Science ®Google Scholar
• Frioni A, Conte MP, Cutone A, Longhi C, Musci G, di Patti MC, Natalizi T, Marazzato M, Lepanto MS, Puddu P, et al. Lactoferrin differently modulates the inflammatory response in epithelial models mimicking human inflammatory and infectious diseases. Biometals. 2014;27(5):843–56. doi: 10.1007/s10534-014-9740-9. Epub 2014 Apr 26. PMID: 24770943.
   PubMed Web of Science ®Google Scholar
• Padhan K, Minakshi R, Towheed MAB, Jameel S. Severe acute respiratory syndrome coronavirus 3a protein activates the mitochondrial death pathway through p38 MAP kinase activation. J Gen Virol. 2008;89(Pt 8):1960–9. doi:10.1099/vir.0.83665-0. PMID: 18632968.
   PubMedGoogle Scholar
• Bonaccorsi di Patti MC, Cutone A, Polticelli F, Rosa L, Lepanto MS, Valenti P, Musci G. The ferroportin-ceruloplasmin system and the mammalian iron homeostasis machine: regulatory pathways and the role of lactoferrin. Biometals. 2018;31(3):399–414. doi:10.1007/s10534-018-0087-5. Epub 2018 Feb 16. PMID: 29453656.
   PubMed Web of Science ®Google Scholar
• Lepanto MS, Rosa L, Cutone A, Conte MP, Paesano R, Valenti P. Efficacy of lactoferrin oral administration in the treatment of anemia and anemia of inflammation in pregnant and non-pregnant women: an interventional study. Front Immunol. 2018;9:2123. doi:10.3389/fimmu.2018.02123. PMID: 30298070; PMCID: PMC6160582.
   PubMed Web of Science ®Google Scholar
• Zakharova ET, Kostevich VA, Sokolov AV, Vasilyev VB. Human apo-lactoferrin as a physiological mimetic of hypoxia stabilizes hypoxia-inducible factor-1 alpha. Biometals. 2012;25(6):1247–59. doi:10.1007/s10534-012-9586-y. Epub 2012 Sep 22. PMID: 23001680.
   PubMedGoogle Scholar
• Zakharova ET, Sokolov AV, Pavlichenko NN, Kostevich VA, Abdurasulova IN, Chechushkov AV, Voynova IV, Elizarova AY, Kolmakov NN, Bass MG, et al. Erythropoietin and Nrf2: key factors in the neuroprotection provided by apo-lactoferrin. Biometals. 2018;31(3):425–43. doi:10.1007/s10534-018-0111-9. Epub 2018 May 10. PMID: 29748743.
   PubMed Web of Science ®Google Scholar
• Ibuki M, Shoda C, Miwa Y, Ishida A, Tsubota K, Kurihara T. Lactoferrin has a therapeutic effect via hif inhibition in a murine model of choroidal neovascularization. Front Pharmacol. 2020;11:174. doi:10.3389/fphar.2020.00174.PMID: 32180725; PMCID: PMC7059857.
   PubMedGoogle Scholar
• Lee NY, Cheng JT, Enomoto T, Nakamura I. The antihypertensive activity of angiotensin-converting enzyme inhibitory peptide containing in bovine lactoferrin. Chin J Physiol. 2006; 49(2):67–73. PMID: 16830788.
   PubMed Web of Science ®Google Scholar
• Fernández-Musoles R, Castelló-Ruiz M, Arce C, Manzanares P, Ivorra MD, Salom JB. Antihypertensive mechanism of lactoferrin-derived peptides: angiotensin receptor blocking effect. J Agric Food Chem. 2014;62(1):173–81. Epub 2013 Dec 26. PMID: 24354413. doi:10.1021/jf404616f.
   PubMed Web of Science ®Google Scholar
• Berlutti F, Pantanella F, Natalizi T, Frioni A, Paesano R, Polimeni A, Valenti P . Antiviral properties of lactoferrin-a natural immunity molecule. Molecules. 2011;16(8):6992–7018. doi:10.3390/molecules16086992. PMID: 21847071; PMCID: PMC6264778.
   PubMed Web of Science ®Google Scholar
• Wakabayashi H, Oda H, Yamauchi K, Abe F. Lactoferrin for prevention of common viral infections. J Infect Chemother. 2014;20(11):666–71. doi:10.1016/j.jiac.2014.08.003. Epub 2014 Aug 30. PMID: 25182867.
   PubMed Web of Science ®Google Scholar
• Ryter SW, Choi AM. Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation. Transl Res. 2016;167(1):7–34. doi:10.1016/j.trsl.2015.06.011. Epub 2015 Jun 23. PMID: 26166253; PMCID: PMC4857893.
   PubMed Web of Science ®Google Scholar
• Nitti M, Furfaro AL, Mann GE. Heme oxygenase dependent bilirubin generation in vascular cells: A role in preventing endothelial dysfunction in local tissue microenvironment? Front Physiol. 2020;11:23. doi:10.3389/fphys.2020.00023. PMID: 32082188; PMCID: PMC7000760.
   PubMedGoogle Scholar
• Luu Hoang KN, Anstee JE, Arnold JN. The diverse roles of heme oxygenase-1 in tumor progression. Front Immunol. 2021;112:658315. doi:10.3389/fimmu.2021.658315. PMID: 33868304; PMCID: PMC8044534.
   PubMedGoogle Scholar
• Campbell NK, Fitzgerald HK, Dunne A. Regulation of inflammation by the antioxidant haem oxygenase 1. Nat Rev Immunol. 2021;21(7):411–25. doi:10.1038/s41577-020-00491-x. Epub 2021 Jan 29. PMID: 33514947.
   PubMed Web of Science ®Google Scholar
• Vijayan V, Wagener F, Immenschuh S. The macrophage heme-heme oxygenase-1 system and its role in inflammation. Biochem Pharmacol. 2018;153:159–67. doi:10.1016/j.bcp.2018.02.010. Epub 2018 Feb 13. PMID: 29452096.
   PubMed Web of Science ®Google Scholar
• Shibahara S, Han F, Li B, Takeda K. Hypoxia and heme oxygenases: oxygen sensing and regulation of expression. Antioxid Redox Signal. 2007;9(12):2209–25. doi:10.1089/ars.2007.1784. PMID: 17887916.
   PubMedGoogle Scholar
• Ryter SW, Tyrrell RM. The heme synthesis and degradation pathways: role in oxidant sensitivity. Heme oxygenase has both pro- and antioxidant properties. Free Radic Biol Med. 2000;28(2):289–309. PMID: 11281297. doi:10.1016/S0891-5849(99)00223-3.
   PubMed Web of Science ®Google Scholar
• Gáll T, Balla G, Balla J. Heme, heme oxygenase, and endoplasmic reticulum stress-A new insight into the pathophysiology of vascular diseases. Int J Mol Sci. 2019;20(15):3675. doi:10.3390/ijms20153675.PMID: 31357546; PMCID: PMC6695876.
   PubMedGoogle Scholar
• Consoli V, Sorrenti V, Grosso S, Vanella L. Heme oxygenase-1 signaling and redox homeostasis in physio-pathological conditions. Biomolecules. 2021;11(4):589. PMID: 33923744; PMCID: PMC8072688. doi:10.3390/biom11040589.
   PubMedGoogle Scholar
• Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. 2021;93(1):250–6. doi:10.1002/jmv.26232. Epub 2020 Sep 30. PMID: 32592501; PMCID: PMC7361342.
   PubMed Web of Science ®Google Scholar
• Surh YJ, Kundu JK, Na HK. Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Med. 2008;74(13):1526–39. doi:10.1055/s-0028-1088302. Epub 2008 Oct 20. PMID: 18937164.
   PubMed Web of Science ®Google Scholar
• Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, O’Meara MJ, Rezelj VV, Guo JZ, Swaney DL, et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020;583(7816):459–68. doi: 10.1038/s41586-020-2286-9. Epub 2020 Apr 30. PMID: 32353859; PMCID: PMC7431030.
   PubMed Web of Science ®Google Scholar
• Siu KL, Yuen KS, Castaño-Rodriguez C, Ye ZW, Yeung ML, Fung SY, Yuan S, Chan CP, Yuen KY, Enjuanes L, et al. Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC. Faseb J. 2019;33(8):8865–77. doi:10.1096/fj.201802418R. Epub 2019 Apr 29. PMID: 31034780; PMCID: PMC6662968.
   PubMed Web of Science ®Google Scholar
• Batra N, De Souza C, Batra J, Raetz AG, Yu AM. The HMOX1 pathway as a promising target for the treatment and prevention of SARS-CoV-2 of 2019 (COVID-19). IJMS. 2020;21(17):6412. PMID: 32899231; PMCID: PMC7503392. doi:10.3390/ijms21176412.
   Google Scholar
• Rossi M, Piagnerelli M, Van Meerhaeghe A, Zouaoui Boudjeltia K. Heme oxygenase-1 (HO-1) cytoprotective pathway: a potential treatment strategy against coronavirus disease 2019 (COVID-19)-induced cytokine storm syndrome. Med Hypotheses. 2020;144:110242. doi:10.1016/j.mehy.2020.110242. Epub 2020 Sep 3. PMID: 33254548; PMCID: PMC7467863.
   PubMedGoogle Scholar
• Ribes A, Vardon-Bounes F, Mémier V, Poette M, Au-Duong J, Garcia C, Minville V, Sié P, Bura-Rivière A, Voisin S, et al. Thromboembolic events and Covid-19. Adv Biol Regul. 2020;77:100735. doi:10.1016/j.jbior.2020.100735. Epub 2020 Jun 17. PMID: 32773098; PMCID: PMC7833411.
   PubMedGoogle Scholar
• Singh D, Wasan H, Reeta KH. Heme oxygenase-1 modulation: a potential therapeutic target for COVID-19 and associated complications. Free Radic Biol Med. 2020;161:263–71. doi:10.1016/j.freeradbiomed.2020.10.016. Epub 2020 Oct 19. PMID: 33091573; PMCID: PMC7571447.
   PubMed Web of Science ®Google Scholar
• Peng L, Mundada L, Stomel JM, Liu JJ, Sun J, Yet SF, Fay WP. Induction of heme oxygenase-1 expression inhibits platelet-dependent thrombosis. Antioxid Redox Signal. 2004;6(4):729–35. doi:10.1089/1523086041361677. PMID: 15242554.
   PubMedGoogle Scholar
• Lindenblatt N, Bordel R, Schareck W, Menger MD, Vollmar B. Vascular heme oxygenase-1 induction suppresses microvascular thrombus formation in vivo. Arterioscler Thromb Vasc Biol. 2004;24(3):601–6. doi:10.1161/01.ATV.0000118279.74056.8a. Epub 2004 Jan 22. PMID: 14739126.
   PubMed Web of Science ®Google Scholar
• True AL, Olive M, Boehm M, San H, Westrick RJ, Raghavachari N, Xu X, Lynn EG, Sack MN, Munson PJ, et al. Heme oxygenase-1 deficiency accelerates formation of arterial thrombosis through oxidative damage to the endothelium, which is rescued by inhaled carbon monoxide. Circ Res. 2007;101(9):893–901. doi:10.1161/CIRCRESAHA.107.158998. Epub 2007 Sep 20. PMID: 17885218.
   PubMedGoogle Scholar
• Mahapatra S, Young CY, Kohli M, Karnes RJ, Klee EW, Holmes MW, Tindall DJ, Donkena KV. Antiangiogenic effects and therapeutic targets of Azadirachta indica leaf extract in endothelial cells. Evid Based Complement Alternat Med. 2012;2012:303019. doi:10.1155/2012/303019. Epub 2012 Feb 22. PMID: 22461839; PMCID: PMC3296311.
   PubMedGoogle Scholar
• Chen CY, Jang JH, Li MH, Surh YJ. Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochem Biophys Res Commun. 2005;331(4):993–1000. doi:10.1016/j.bbrc.2005.03.237. PMID: 15882976.
   PubMed Web of Science ®Google Scholar
• Jeong S-O, Oh G-S, Ha H-Y, Soon Koo B, Sung Kim H, Kim Y-C, Kim E-C, Lee K-M, Chung H-T, Pae H-O. Dimethoxycurcumin, a synthetic curcumin analogue, induces heme oxygenase-1 expression through Nrf2 activation in RAW264.7 macrophages. J Clin Biochem Nutr. 2009;44(1):79–84. doi: 10.3164/jcbn.08-194. Epub 2008 Dec 27. PMID: 19177192; PMCID: PMC2613503.
   PubMedGoogle Scholar
• Yao P, Nussler A, Liu L, Hao L, Song F, Schirmeier A, Nussler N. Quercetin protects human hepatocytes from ethanol-derived oxidative stress by inducing heme oxygenase-1 via the MAPK/Nrf2 pathways. J Hepatol. 2007;47(2):253–61. doi:10.1016/j.jhep.2007.02.008. Epub 2007 Mar 7. PMID: 17433488.
   PubMed Web of Science ®Google Scholar
• De Maio A, Hightower LE. COVID-19, acute respiratory distress syndrome (ARDS), and hyperbaric oxygen therapy (HBOT): what is the link? Cell Stress Chaperones. 2020;25(5):717–20. doi:10.1007/s12192-020-01121-0. PMID: 32424591; PMCID: PMC7232923.
   PubMed Web of Science ®Google Scholar
• Godman CA, Chheda KP, Hightower LE, Perdrizet G, Shin DG, Giardina C. Hyperbaric oxygen induces a cytoprotective and angiogenic response in human microvascular endothelial cells. Cell Stress Chaperones. 2010;15(4):431–42. doi: 10.1007/s12192-009-0159-0. Epub 2009 Dec 1. PMID: 19949909; PMCID: PMC3082642.
   PubMed Web of Science ®Google Scholar
• Krantz SB. Erythropoietin. Blood. 1991;77(3):419–34. PMID: 1991159.
   PubMedGoogle Scholar
• Bunn HF, Gu J, Huang LE, Park JW, Zhu H. Erythropoietin: a model system for studying oxygen-dependent gene regulation. J Exp Biol. 1998;201(Pt 8):1197–201. PMID: 9510530; PMCID: PMC3044471. doi:10.1242/jeb.201.8.1197.
   PubMedGoogle Scholar
• Hildebrandt W, Alexander S, Bärtsch P, Dröge W. Effect of N-acetyl-cysteine on the hypoxic ventilatory response and erythropoietin production: linkage between plasma thiol redox state and O(2) chemosensitivity. Blood. 2002;99(5):1552–5. doi: 10.1182/blood.v99.5.1552. PMID: 11861267.
   PubMedGoogle Scholar
• Hadadi A, Mortezazadeh M, Kolahdouzan K, Alavian G. Does recombinant human erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects? J Med Virol. 2020;92(7):915–8. Epub 2020 Apr 19. PMID: 32270515; PMCID: PMC7262240. doi:10.1002/jmv.25839.
   PubMed Web of Science ®Google Scholar
• Bailey DM, Robach P, Thomsen JJ, Lundby C. Erythropoietin depletes iron stores: antioxidant neuroprotection for ischemic stroke? Stroke. 2006;37(10):2453. doi:10.1161/01.STR.0000239787.92203.16. Epub 2006 Aug 17. PMID: 16917084.
   PubMed Web of Science ®Google Scholar
• Schobersberger W, Hoffmann G, Fandrey J. Nitric oxide donors suppress erythropoietin production in vitro. Pflugers Arch. 1996;432(6):980–5. doi:10.1007/s004240050225. PMID: 8781191.
   PubMedGoogle Scholar
• Viruez-Soto A, López-Dávalos MM, Rada-Barrera G, Merino-Luna A, Molano-Franco D, Tinoco-Solorozano A, Zubieta-DeUrioste N, Zubieta-Calleja G, Arias-Reyes C, Soliz J. Low serum erythropoietin levels are associated with fatal COVID-19 cases at 4,150 meters above sea level. Respir Physiol Neurobiol. 2021;292:103709. doi:10.1016/j.resp.2021.103709. Epub 2021 Jun 2. PMID: 34087493; PMCID: PMC8169280.
   PubMedGoogle Scholar
• Ehrenreich H, Weissenborn K, Begemann M, Busch M, Vieta E, Miskowiak KW. Erythropoietin as candidate for supportive treatment of severe COVID-19. Mol Med. 2020;26(1):58. doi:10.1186/s10020-020-00186-y. PMID: 32546125; PMCID: PMC7297268.
   PubMedGoogle Scholar
• Soliz J, Schneider-Gasser EM, Arias-Reyes C, Aliaga-Raduan F, Poma-Machicao L, Zubieta-Calleja G, Furuya WI, Trevizan-Baú P, Dhingra RR, Dutschmann M. Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19? Respir Physiol Neurobiol. 2020;279:103476. doi:10.1016/j.resp.2020.103476. Epub 2020 Jun 6. PMID: 32522574; PMCID: PMC7275159.
   PubMed Web of Science ®Google Scholar
• Suresh S, Rajvanshi PK, Noguchi CT. The many facets of erythropoietin physiologic and metabolic response. Front Physiol. 2019;10:1534. doi:10.3389/fphys.2019.01534. PMID: 32038269; PMCID: PMC6984352.
   PubMed Web of Science ®Google Scholar
• Peng B, Kong G, Yang C, Ming Y. Erythropoietin and its derivatives: from tissue protection to immune regulation. Cell Death Dis. 2020;11(2):79. doi:10.1038/s41419-020-2276-8. PMID: 32015330; PMCID: PMC6997384.
   PubMed Web of Science ®Google Scholar
• Sahebnasagh A, Mojtahedzadeh M, Najmeddin F, Najafi A, Safdari M, Rezai Ghaleno H, Habtemariam S, Berindan-Neagoe I, Nabavi SM. A perspective on erythropoietin as a potential adjuvant therapy for acute lung injury/acute respiratory distress syndrome in patients with COVID-19. Arch Med Res. 2020;51(7):631–5. doi:10.1016/j.arcmed.2020.08.002. Epub 2020 Aug 11. PMID: 32863034; PMCID: PMC7418647.
   PubMedGoogle Scholar
• Cao F, Tian X, Li Z, Lv Y, Han J, Zhuang R, Cheng B, Gong Y, Ying B, Jin S, et al. Suppression of NLRP3 inflammasome by erythropoietin via the EPOR/JAK2/STAT3 pathway contributes to attenuation of acute lung injury in mice. Front Pharmacol. 2020;11:306. doi:10.3389/fphar.2020.00306. PMID: 32265704; PMCID: PMC7096553.
   PubMed Web of Science ®Google Scholar
• Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, Greninger AL, Pipavath S, Wurfel MM, Evans L, et al. Covid-19 in Critically Ill Patients in the Seattle Region - Case Series. N Engl J Med. 2020;382(21):2012–22. doi:10.1056/NEJMoa2004500. Epub 2020 Mar 30. PMID: 32227758; PMCID: PMC7143164.
   PubMed Web of Science ®Google Scholar
• Solaimanzadeh I. Acetazolamide, nifedipine and phosphodiesterase inhibitors: rationale for their utilization as adjunctive countermeasures in the treatment of coronavirus disease 2019 (COVID-19). Cureus. 2020;12(3):e7343. doi:10.7759/cureus.7343. PMID: 32226695; PMCID: PMC7096066.
   PubMed Web of Science ®Google Scholar
• Nairz M, Sonnweber T, Schroll A, Theurl I, Weiss G. The pleiotropic effects of erythropoietin in infection and inflammation. Microbes Infect. 2012;14(3):238–46. doi:10.1016/j.micinf.2011.10.005. Epub 2011 Nov 4. PMID: 22094132; PMCID: PMC3278592.
   PubMedGoogle Scholar
• Collantes MEV, Espiritu AI, Sy MCC, Anlacan VMM, Jamora RDG. Neurological manifestations in COVID-19 infection: a systematic review and meta-analysis. Can J Neurol Sci. 2021;48(1):66–76. doi:10.1017/cjn.2020.146. Epub 2020 Jul 15. PMID: 32665054; PMCID: PMC7492583.
   PubMedGoogle Scholar
• Caravagna C, Soliz J. PI3K and MEK1/2 molecular pathways are involved in the erythropoietin-mediated regulation of the central respiratory command. Respir Physiol Neurobiol. 2015;206:36–40. doi:10.1016/j.resp.2014.11.012. Epub 2014 Nov 21. PMID: 25462838.
   PubMedGoogle Scholar
• Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, Vaulont S. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci U S A. 2001;98(15):8780–5. doi:10.1073/pnas.151179498. Epub 2001 Jul 10. PMID: 11447267; PMCID: PMC37512.
   PubMed Web of Science ®Google Scholar
• Daher R, Karim Z. Iron metabolism: state of the art. Transfus Clin Biol. 2017;24(3):115–9. doi:10.1016/j.tracli.2017.06.015. Epub 2017 Jul 8. PMID: 28694024.
   PubMed Web of Science ®Google Scholar
• Palaneeswari MS, Ganesh M, Karthikeyan T, Devi AJ, Mythili SV. Hepcidin-minireview. J Clin Diagn Res. 2013;7(8):1767–71. doi:10.7860/JCDR/2013/6420.3273. Epub 2013 Aug 1. PMID: 24086909; PMCID: PMC3782966.
   PubMedGoogle Scholar
• Ravasi G, Pelucchi S, Trombini P, Mariani R, Tomosugi N, Modignani GL, Pozzi M, Nemeth E, Ganz T, Hayashi H, et al. Hepcidin expression in iron overload diseases is variably modulated by circulating factors. PLoS One. 2012;7(5):e36425. doi:10.1371/journal.pone.0036425. Epub 2012 May 7. PMID: 22586470; PMCID: PMC3346721.
   PubMedGoogle Scholar
• Parrow NL, Fleming RE. Bone morphogenetic proteins as regulators of iron metabolism. Annu Rev Nutr. 2014;34:77–94. doi:10.1146/annurev-nutr-071813-105646. Epub 2014 Jun 6. PMID: 24995692; PMCID: PMC7713507.
   PubMedGoogle Scholar
• Chen S, Feng T, Vujić Spasić M, Altamura S, Breitkopf-Heinlein K, Altenöder J, Weiss TS, Dooley S, Muckenthaler MU. Transforming Growth Factor β1 (TGF-β1) Activates Hepcidin mRNA Expression in Hepatocytes. J Biol Chem. 2016;291(25):13160–74. doi:10.1074/jbc.M115.691543. Epub 2016 Apr 27. PMID: 27129231; PMCID: PMC4933231.
   PubMed Web of Science ®Google Scholar
• Banchini F, Vallisa D, Maniscalco P, Capelli P. Iron overload and Hepcidin overexpression could play a key role in COVID infection, and may explain vulnerability in elderly, diabetics, and obese patients. Acta Biomed. 2020;91(3):e2020013. doi:10.23750/abm.v91i3.9826. PMID: 32921750; PMCID: PMC7716981.
   PubMedGoogle Scholar
• Blanchette NL, Manz DH, Torti FM, Torti SV. Modulation of hepcidin to treat iron deregulation: potential clinical applications. Expert Rev Hematol. 2016;9(2):169–86. doi:10.1586/17474086.2016.1124757. Epub 2015 Dec 15. PMID: 26669208; PMCID: PMC4849272.
   PubMed Web of Science ®Google Scholar
• Pietrangelo A. Hepcidin in human iron disorders: therapeutic implications. J Hepatol. 2011;54(1):173–81. doi:10.1016/j.jhep.2010.08.004. Epub 2010 Aug 26. PMID: 20932599.
   PubMed Web of Science ®Google Scholar
• Luo X, Luo Z, Zhang Z, Yang H, Lai B, Yao Q, Xiao L, Wang N. Homocysteine upregulates hepcidin expression through BMP6/SMAD signaling pathway in hepatocytes. Biochem Biophys Res Commun. 2016;471(2):303–8. doi:10.1016/j.bbrc.2016.02.001. Epub 2016 Feb 15. PMID: 26855134.
   PubMedGoogle Scholar
• Lei Y, Zhao C, Chang H, Zhang D, Li Y, Anderson GJ, Shen Y, Duan X, Chang YZ. Calcitonin increases hepatic hepcidin expression through the BMP6 of kidney in mice. J Trace Elem Med Biol. 2021;68:126796. doi:10.1016/j.jtemb.2021.126796. Epub 2021 Jun 1. PMID: 34098241.
   PubMedGoogle Scholar
• Yang L, Wang H, Yang X, Wu Q, An P, Jin X, Liu W, Huang X, Li Y, Yan S, et al. Auranofin mitigates systemic iron overload and induces ferroptosis via distinct mechanisms. Signal Transduct Target Ther. 2020;5(1):138. doi:10.1038/s41392-020-00253-0. PMID: 32732975; PMCID: PMC7393508.
   PubMed Web of Science ®Google Scholar
• Chung B, Verdier F, Matak P, Deschemin JC, Mayeux P, Vaulont S. Oncostatin M is a potent inducer of hepcidin, the iron regulatory hormone. Faseb J. 2010;24(6):2093–103. doi:10.1096/fj.09-152561. Epub 2010 Feb 2. PMID: 20124431.
   PubMedGoogle Scholar
• Zhen AW, Nguyen NH, Gibert Y, Motola S, Buckett P, Wessling-Resnick M, Fraenkel E, Fraenkel PG. The small molecule, genistein, increases hepcidin expression in human hepatocytes. Hepatology. 2013;58(4):1315–25. doi:10.1002/hep.26490. Epub 2013 Aug 19. PMID: 23703590; PMCID: PMC3770762.
   PubMed Web of Science ®Google Scholar
• Bayele HK, Balesaria S, Srai SK. Phytoestrogens modulate hepcidin expression by Nrf2: Implications for dietary control of iron absorption. Free Radic Biol Med. 2015;89:1192–202. doi:10.1016/j.freeradbiomed.2015.11.001. Epub 2015 Nov 10. PMID: 26546695; PMCID: PMC4698393.
   PubMedGoogle Scholar
• Kim EY, Ham SK, Shigenaga MK, Han O. Bioactive dietary polyphenolic compounds reduce nonheme iron transport across human intestinal cell monolayers. J Nutr. 2008;138(9):1647–51. PMID: 18716164. doi:10.1093/jn/138.9.1647.
   PubMed Web of Science ®Google Scholar
• Perron NR, Brumaghim JL. A review of the antioxidant mechanisms of polyphenol compounds related to iron binding. Cell Biochem Biophys. 2009;53(2):75–100. doi:10.1007/s12013-009-9043-x. PMID: 19184542.
   PubMed Web of Science ®Google Scholar
• Kaltwasser JP, Werner E, Schalk K, Hansen C, Gottschalk R, Seidl C. Clinical trial on the effect of regular tea drinking on iron accumulation in genetic haemochromatosis. Gut. 1998;43(5):699–704. doi: 10.1136/gut.43.5.699. PMID: 9824354; PMCID: PMC1727318.
   PubMedGoogle Scholar
• Habib HM, Ibrahim S, Zaim A, Ibrahim WH. The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators. Biomed Pharmacother. 2021;136:111228. doi: 10.1016/j.biopha.2021.111228. Epub 2021 Jan 13. PMID: 33454595; PMCID: PMC7836924.
   PubMed Web of Science ®Google Scholar
• Okada K, Warabi E, Sugimoto H, Horie M, Tokushige K, Ueda T, Harada N, Taguchi K, Hashimoto E, Itoh K, et al. Nrf2 inhibits hepatic iron accumulation and counteracts oxidative stress-induced liver injury in nutritional steatohepatitis. J Gastroenterol. 2012;47(8):924–35. doi:10.1007/s00535-012-0552-9. Epub 2012 Feb 28. PMID: 22367278.
   PubMedGoogle Scholar
• Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–72. doi:10.1016/j.cell.2012.03.042. PMID: 22632970; PMCID: PMC3367386.
   PubMed Web of Science ®Google Scholar
• Sun Y, Chen P, Zhai B, Zhang M, Xiang Y, Fang J, Xu S, Gao Y, Chen X, Sui X, et al. The emerging role of ferroptosis in inflammation. Biomed Pharmacother. 2020;127:110108. doi:10.1016/j.biopha.2020.110108. Epub 2020 Mar 29. PMID: 32234642.
   PubMed Web of Science ®Google Scholar
• Stockwell BR, Jiang X. The chemistry and biology of ferroptosis. Cell Chem Biol. 2020;27(4):365–75. doi:10.1016/j.chembiol.2020.03.013. PMID: 32294465; PMCID: PMC7204503.
   PubMed Web of Science ®Google Scholar
• Qiu YB, Wan BB, Liu G, Wu YX, Chen D, Lu MD, Chen JL, Yu RQ, Chen DZ, Pang QF. Nrf2 protects against seawater drowning-induced acute lung injury via inhibiting ferroptosis. Respir Res. 2020;21(1):232. doi:10.1186/s12931-020-01500-2. PMID: 32907551; PMCID: PMC7488337.
   PubMed Web of Science ®Google Scholar
• Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, Roberts MA, Tong B, Maimone TJ, Zoncu R, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575(7784):688–92. doi:10.1038/s41586-019-1705-2. Epub 2019 Oct 21. PMID: 31634900; PMCID: PMC6883167.
   PubMed Web of Science ®Google Scholar
• Fan BY, Pang YL, Li WX, Zhao CX, Zhang Y, Wang X, Ning GZ, Kong XH, Liu C, Yao X, et al. Liproxstatin-1 is an effective inhibitor of oligodendrocyte ferroptosis induced by inhibition of glutathione peroxidase 4. Neural Regen Res. 2021;16(3):561–6. doi:10.4103/1673-5374.293157. PMID: 32985488; PMCID: PMC7996026.
   PubMedGoogle Scholar
• Zilka O, Shah R, Li B, Friedmann Angeli JP, Griesser M, Conrad M, Pratt DA. On the mechanism of cytoprotection by ferrostatin-1 and Liproxstatin-1 and the role of lipid peroxidation in ferroptotic cell death. ACS Cent Sci. 2017;3(3):232–43. doi:10.1021/acscentsci.7b00028. Epub 2017 Mar 7. PMID: 28386601; PMCID: PMC5364454.
   PubMed Web of Science ®Google Scholar
• Hu B, Liu Y, Chen X, Zhao J, Han J, Dong H, Zheng Q, Nie G. Ferrostatin-1 protects auditory hair cells from cisplatin-induced ototoxicity in vitro and in vivo. Biochem Biophys Res Commun. 2020;533(4):1442–8. doi: 10.1016/j.bbrc.2020.10.019. Epub 2020 Oct 24. PMID: 33109343.
   PubMed Web of Science ®Google Scholar
• Miotto G, Rossetto M, Di Paolo ML, Orian L, Venerando R, Roveri A, Vučković AM, Bosello Travain V, Zaccarin M, Zennaro L, et al. Insight into the mechanism of ferroptosis inhibition by ferrostatin-1. Redox Biol. 2020;28:101328. doi:10.1016/j.redox.2019.101328. Epub 2019 Sep 20. PMID: 31574461; PMCID: PMC6812032.
   PubMed Web of Science ®Google Scholar
• Hofmans S, Vanden Berghe T, Devisscher L, Hassannia B, Lyssens S, Joossens J, Van Der Veken P, Vandenabeele P, Augustyns K. Novel ferroptosis inhibitors with improved Potency and ADME properties. J Med Chem. 2016;59(5):2041–53. doi: 10.1021/acs.jmedchem.5b01641. Epub 2016 Feb 8. PMID: 26696014.
   PubMed Web of Science ®Google Scholar
• Chen B, Li X, Ouyang X, Liu J, Liu Y, Chen D. Comparison of ferroptosis-inhibitory mechanisms between ferrostatin-1 and dietary stilbenes (Piceatannol and Astringin). Molecules. 2021;26(4):1092. PMID: 33669598; PMCID: PMC7922211. doi:10.3390/molecules26041092.
   PubMedGoogle Scholar
• Cao Y, Li Y, He C, Yan F, Li JR, Xu HZ, Zhuang JF, Zhou H, Peng YC, Fu XJ, et al. Selective ferroptosis inhibitor liproxstatin-1 attenuates neurological deficits and neuroinflammation after subarachnoid hemorrhage. Neurosci Bull. 2021;37(4):535–49. doi:10.1007/s12264-020-00620-5. Epub 2021 Jan 9. PMID: 33421025; PMCID: PMC8055759.
   PubMedGoogle Scholar
• Ma H, Wang X, Zhang W, Li H, Zhao W, Sun J, Yang M. Melatonin suppresses ferroptosis induced by high glucose via activation of the Nrf2/HO-1 signaling pathway in type 2 diabetic osteoporosis. Oxid Med Cell Longev. 2020;2020:9067610. doi:10.1155/2020/9067610. PMID: 33343809; PMCID: PMC7732386.
   PubMed Web of Science ®Google Scholar
• Naveenkumar SK, Hemshekhar M, Kemparaju K, Girish KS. Hemin-induced platelet activation and ferroptosis is mediated through ROS-driven proteasomal activity and inflammasome activation: Protection by Melatonin. Biochim Biophys Acta Mol Basis Dis. 2019;1865(9):2303–16. doi:10.1016/j.bbadis.2019.05.009. Epub 2019 May 16. PMID: 31102787.
   PubMed Web of Science ®Google Scholar
• Han F, Li S, Yang Y, Bai Z. Interleukin-6 promotes ferroptosis in bronchial epithelial cells by inducing reactive oxygen species-dependent lipid peroxidation and disrupting iron homeostasis. Bioengineered. 2021;12(1):5279–88. doi: 10.1080/21655979.2021.1964158. PMID: 34402724.
   PubMed Web of Science ®Google Scholar
• Shao Y, Saredy J, Xu K, Sun Y, Saaoud F, Drummer C, Lu Y, Luo JJ, Lopez-Pastrana J, Choi ET, et al. Endothelial immunity trained by coronavirus infections, DAMP stimulations and regulated by anti-oxidant NRF2 may contribute to inflammations, myelopoiesis, COVID-19 cytokine storms and thromboembolism. Front Immunol. 2021;12:653110. doi:10.3389/fimmu.2021.653110. PMID: 34248940; PMCID: PMC8269631.
   PubMed Web of Science ®Google Scholar
• Du J, Zhou Y, Li Y, Xia J, Chen Y, Chen S, Wang X, Sun W, Wang T, Ren X, et al. Identification of frataxin as a regulator of ferroptosis. Redox Biol. 2020;32:101483. doi:10.1016/j.redox.2020.101483. Epub 2020 Mar 2. PMID: 32169822; PMCID: PMC7068686.
   PubMed Web of Science ®Google Scholar
• Yang L, Liu Y, Zhang W, Hua Y, Chen B, Wu Q, Chen D, Liu S, Li X. Ferroptosis-Inhibitory Difference between Chebulagic Acid and Chebulinic Acid Indicates Beneficial Role of HHDP. Molecules. 2021;26(14):4300. PMID: 34299576; PMCID: PMC8303713. doi:10.3390/molecules26144300.
   PubMedGoogle Scholar
• Guerrero-Hue M, García-Caballero C, Palomino-Antolín A, Rubio-Navarro A, Vázquez-Carballo C, Herencia C, Martín-Sanchez D, Farré-Alins V, Egea J, Cannata P, et al. Curcumin reduces renal damage associated with rhabdomyolysis by decreasing ferroptosis-mediated cell death. Faseb J. 2019;33(8):8961–75. doi: 10.1096/fj.201900077R. Epub 2019 Apr 29. PMID: 31034781.
   PubMed Web of Science ®Google Scholar
• Lin CC, Wang PH. Intravenous glycyrrhizin improved serum transaminases rapidly in a chronic hepatitis B patient with acute exacerbation. J Formos Med Assoc. 2015;114(2):188–9. doi:10.1016/j.jfma.2012.08.012. Epub 2012 Sep 7. PMID: 25678183.
   PubMedGoogle Scholar
• Wang Y, Chen Q, Shi C, Jiao F, Gong Z. Mechanism of glycyrrhizin on ferroptosis during acute liver failure by inhibiting oxidative stress. Mol Med Rep. 2019;20(5):4081–90. doi:10.3892/mmr.2019.10660. Epub 2019 Sep 10. PMID: 31545489; PMCID: PMC6797988.
   PubMed Web of Science ®Google Scholar
• Barrett CD, Moore HB, Yaffe MB, Moore EE. ISTH interim guidance on recognition and management of coagulopathy in COVID-19: a comment. J Thromb Haemost. 2020;18(8):2060–3. doi:10.1111/jth.14860. Epub 2020 Jun 14. PMID: 32302462.
   PubMed Web of Science ®Google Scholar
• Giannis D, Ziogas IA, Gianni P. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. J Clin Virol. 2020;127:104362. doi: 10.1016/j.jcv.2020.104362. Epub 2020 Apr 9. PMID: 32305883; PMCID: PMC7195278.
   PubMed Web of Science ®Google Scholar
• Mulloy B. Structure and physicochemical characterisation of heparin. Handb Exp Pharmacol. 2012;(207):77–98. doi:10.1007/978-3-642-23056-1_5.PMID: 22566222.
   PubMedGoogle Scholar
• Hippensteel JA, LaRiviere WB, Colbert JF, Langouët-Astrié CJ, Schmidt EP. Heparin as a therapy for COVID-19: current evidence and future possibilities. Am J Physiol Lung Cell Mol Physiol. 2020;319(2):L211–L217. doi: 10.1152/ajplung.00199.2020. Epub 2020 Jun 10. PMID: 32519894; PMCID: PMC7381711.
   PubMed Web of Science ®Google Scholar
• Lindahl U, Li JP. Heparin - An old drug with multiple potential targets in Covid-19 therapy. J Thromb Haemost. 2020;18(9):2422–4. doi:10.1111/jth.14898. Epub 2020 Aug 27. PMID: 32426897; PMCID: PMC7276884.
   PubMedGoogle Scholar
• Young E. The anti-inflammatory effects of heparin and related compounds. Thromb Res. 2008;122(6):743–52. doi:10.1016/j.thromres.2006.10.026. Epub 2007 Aug 28. PMID: 17727922.
   PubMed Web of Science ®Google Scholar
• Hao C, Xu H, Yu L, Zhang L. Heparin: an essential drug for modern medicine. Prog Mol Biol Transl Sci. 2019;163:1–19. doi:10.1016/bs.pmbts.2019.02.002. Epub 2019 Mar 21. PMID: 31030744.
   PubMedGoogle Scholar
• Li X, Li L, Shi Y, Yu S, Ma X. Different signaling pathways involved in the anti-inflammatory effects of unfractionated heparin on lipopolysaccharide-stimulated human endothelial cells. J Inflamm (Lond). 2020;17:5. doi:10.1186/s12950-020-0238-7. PMID: 32063752; PMCID: PMC7011532.
   PubMedGoogle Scholar
• Shi C, Tingting W, Li JP, Sullivan MA, Wang C, Wang H, Deng B, Zhang Y. Comprehensive landscape of heparin therapy for COVID-19. Carbohydr Polym. 2021;254:117232. doi:10.1016/j.carbpol.2020.117232. Epub 2020 Oct 22. PMID: 33357843; PMCID: PMC7581413.
   PubMedGoogle Scholar
• Yan Y, Ji Y, Su N, Mei X, Wang Y, Du S, Zhu W, Zhang C, Lu Y, Xing XH. Non-anticoagulant effects of low molecular weight heparins in inflammatory disorders: A review. Carbohydr Polym. 2017;160:71–81. doi:10.1016/j.carbpol.2016.12.037. Epub 2016 Dec 21. PMID: 28115102.
   PubMedGoogle Scholar
• Negri EM, Piloto BM, Morinaga LK, Jardim CVP, Lamy SAE, Ferreira MA, D’Amico EA, Deheinzelin D. Heparin therapy improving hypoxia in COVID-19 patients: a case series. Front Physiol. 2020;11:573044. doi:10.3389/fphys.2020.573044. PMID: 33192569; PMCID: PMC7604350.
   PubMedGoogle Scholar
• Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934–43. doi:10.1001/jamainternmed.2020.0994. Erratum in: JAMA Intern Med. 2020 Jul 1;180(7):1031. PMID: 32167524; PMCID: PMC7070509.
   PubMed Web of Science ®Google Scholar
• Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7(6):e438–e440. doi:10.1016/S2352-3026(20)30145-9. Epub 2020 May 11. PMID: 32407672; PMCID: PMC7213964.
   PubMed Web of Science ®Google Scholar
• Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta. 2020;506:145–8. doi:10.1016/j.cca.2020.03.022. Epub 2020 Mar 13. PMID: 32178975; PMCID: PMC7102663.
   PubMed Web of Science ®Google Scholar
• Zhai Z, Kan Q, Li W, Qin X, Qu J, Shi Y, Xu R, Xu Y, Zhang Z, Wang C, DissolVE-2 investigators DissolVE-2 investigators. VTE risk profiles and prophylaxis in medical and surgical inpatients: the identification of chinese hospitalized patients’ risk profile for venous thromboembolism (DissolVE-2)-a cross-sectional study. Chest. 2019;155(1):114–22. doi:10.1016/j.chest.2018.09.020. Epub 2018 Oct 6. PMID: 30300652.
   PubMed Web of Science ®Google Scholar
• Buijsers B, Yanginlar C, Maciej-Hulme ML, de Mast Q, van der Vlag J. Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients. EBioMedicine. 2020;59:102969. doi:10.1016/j.ebiom.2020.102969. Epub 2020 Aug 25. PMID: 32853989; PMCID: PMC7445140.
   PubMed Web of Science ®Google Scholar
• Ayerbe L, Risco C, Ayis S. The association between treatment with heparin and survival in patients with Covid-19. J Thromb Thrombolysis. 2020;50(2):298–301. doi:10.1007/s11239-020-02162-z. PMID: 32476080; PMCID: PMC7261349.
   PubMed Web of Science ®Google Scholar
• van Haren FMP, Page C, Laffey JG, Artigas A, Camprubi-Rimblas M, Nunes Q, Smith R, Shute J, Carroll M, Tree J, et al. Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence. Crit Care. 2020;24(1):454. doi:10.1186/s13054-020-03148-2. PMID: 32698853; PMCID: PMC7374660.
   PubMedGoogle Scholar
• Nieuwenhuis HK, Albada J, Banga JD, Sixma JJ. Identification of risk factors for bleeding during treatment of acute venous thromboembolism with heparin or low molecular weight heparin. Blood. 1991;78(9):2337–43. PMID: 1657248. doi:10.1182/blood.V78.9.2337.bloodjournal7892337.
   PubMed Web of Science ®Google Scholar
• Cossette B, Pelletier ME, Carrier N, Turgeon M, Leclair C, Charron P, Echenberg D, Fayad T, Farand P. Evaluation of bleeding risk in patients exposed to therapeutic unfractionated or low-molecular-weight heparin: a cohort study in the context of a quality improvement initiative. Ann Pharmacother. 2010;44(6):994–1002. Epub 2010 May 4. PMID: 20442353. doi:10.1345/aph.1M615.
   PubMedGoogle Scholar
• Arepally GM. Heparin-induced thrombocytopenia. Blood. 2017;129(21):2864–72. doi:10.1182/blood-2016-11-709873. Epub 2017 Apr 17. PMID: 28416511; PMCID: PMC5445568.
   PubMed Web of Science ®Google Scholar
• Mycroft-West CJ, Su D, Pagani I, Rudd TR, Elli S, Gandhi NS, Guimond SE, Miller GJ, Meneghetti MCZ, Nader HB, et al. Heparin inhibits cellular invasion by SARS-CoV-2: structural dependence of the interaction of the spike s1 receptor-binding domain with heparin. Thromb Haemost. 2020;120(12):1700–15. doi:10.1055/s-0040-1721319. Epub 2020 Dec 23. PMID: 33368089; PMCID: PMC7869224.
   PubMed Web of Science ®Google Scholar
• Ali MK, Kim RY, Brown AC, Donovan C, Vanka KS, Mayall JR, Liu G, Pillar AL, Jones-Freeman B, Xenaki D, et al. Critical role for iron accumulation in the pathogenesis of fibrotic lung disease. J Pathol. 2020;251(1):49–62. doi:10.1002/path.5401. Epub 2020 Mar 30. PMID: 32083318.
   PubMed Web of Science ®Google Scholar
• Toblli JE, Cao G, Giani JF, Dominici FP, Angerosa M. Markers of oxidative/nitrosative stress and inflammation in lung tissue of rats exposed to different intravenous iron compounds. Drug Des Devel Ther. 2017;11:2251–63. doi:10.2147/DDDT.S132612. PMID: 28814833; PMCID: PMC5546731.
   PubMed Web of Science ®Google Scholar
• Carota G, Ronsisvalle S, Panarello F, Tibullo D, Nicolosi A, Li Volti G. Role of iron chelation and protease inhibition of natural products on COVID-19 infection. JCM. 2021; May 2510(11):2306. PMID: 34070628; PMCID: PMC8198259. doi:10.3390/jcm10112306.
   Google Scholar
• Dalamaga M, Karampela I, Mantzoros CS. Commentary: could iron chelators prove to be useful as an adjunct to COVID-19 treatment regimens? Metabolism. 2020;108:154260. doi:10.1016/j.metabol.2020.154260. Epub 2020 May 8. PMID: 32418885; PMCID: PMC7207125.
   PubMed Web of Science ®Google Scholar
• Codd R, Richardson-Sanchez T, Telfer TJ, Gotsbacher MP. Advances in the chemical biology of desferrioxamine B. ACS Chem Biol. 2018;13(1):11–25. doi:10.1021/acschembio.7b00851. Epub 2017 Dec 4. PMID: 29182270.
   PubMedGoogle Scholar
• Hershko C, Konijn AM, Nick HP, Breuer W, Cabantchik ZI, Link G. ICL670A: a new synthetic oral chelator: evaluation in hypertransfused rats with selective radioiron probes of hepatocellular and reticuloendothelial iron stores and in iron-loaded rat heart cells in culture. Blood. 2001;97(4):1115–22. doi: 10.1182/blood.v97.4.1115. PMID: 11159545.
   PubMed Web of Science ®Google Scholar
• Zhu BZ, Har-El R, Kitrossky N, Chevion M. New modes of action of desferrioxamine: scavenging of semiquinone radical and stimulation of hydrolysis of tetrachlorohydroquinone. Free Radic Biol Med. 1998;24(2):360–9. Erratum in: Free Radic Biol Med 1998 Mar 15;24(5):880. PMID: 9433912. doi:10.1016/S0891-5849(97)00220-7.
   PubMedGoogle Scholar
• Liu W, Li H. COVID-19: attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism. ChemRxiv. 2020; doi: 10.26434/chemrxiv.11938173.v8).
   Google Scholar
• Laforge M, Elbim C, Frère C, Hémadi M, Massaad C, Nuss P, Benoliel JJ, Becker C. Tissue damage from neutrophil-induced oxidative stress in COVID-19. Nat Rev Immunol. 2020;20(9):515–6. doi:10.1038/s41577-020-0407-1. Erratum in: Nat Rev Immunol. 2020 Aug 10;: PMID: 32728221; PMCID: PMC7388427.
   PubMed Web of Science ®Google Scholar
• Kontoghiorghes GJ. Advances on chelation and chelator metal complexes in medicine. IJMS. 2020;21(7):2499. PMID: 32260293; PMCID: PMC7177276. doi:10.3390/ijms21072499.
   Google Scholar
• Al-Horani RA, Kar S. Potential anti-SARS-CoV-2 therapeutics that target the post-entry stages of the viral life cycle: a comprehensive review. Viruses. 2020;12(10):1092. PMID: 32993173; PMCID: PMC7600245. doi:10.3390/v12101092.
   PubMed Web of Science ®Google Scholar
• Bataille S, Pedinielli N, Bergounioux JP. Could ferritin help the screening for COVID-19 in hemodialysis patients? Kidney Int. 2020;98(1):235–6. doi:10.1016/j.kint.2020.04.017. Epub 2020 Apr 22. PMID: 32471636; PMCID: PMC7175847.
   PubMedGoogle Scholar
• Turi JL, Yang F, Garrick MD, Piantadosi CA, Ghio AJ. The iron cycle and oxidative stress in the lung. Free Radic Biol Med. 2004;36(7):850–7. doi:10.1016/j.freeradbiomed.2003.12.008. PMID: 15019970.
   PubMedGoogle Scholar
• Dalskov L, Møhlenberg M, Thyrsted J, Blay-Cadanet J, Poulsen ET, Folkersen BH, Skaarup SH, Olagnier D, Reinert L, Enghild JJ, et al. SARS-CoV-2 evades immune detection in alveolar macrophages. EMBO Rep. 2020;21(12):e51252. doi:10.15252/embr.202051252. Epub 2020 Oct 28. PMID: 33112036; PMCID: PMC7645910.
   PubMedGoogle Scholar
• Abobaker A. Can iron chelation as an adjunct treatment of COVID-19 improve the clinical outcome? Eur J Clin Pharmacol. 2020;76(11):1619–20. doi:10.1007/s00228-020-02942-9. Epub 2020 Jun 30. PMID: 32607779; PMCID: PMC7325475.
   PubMedGoogle Scholar
• Visseren F, Verkerk MS, van der Bruggen T, Marx JJ, van Asbeck BS, Diepersloot RJ. Iron chelation and hydroxyl radical scavenging reduce the inflammatory response of endothelial cells after infection with Chlamydia pneumoniae or influenza A. Eur J Clin Invest. 2002;32(Suppl 1):84–90. doi:10.1046/j.1365-2362.2002.0320s1084.x. PMID: 11886437.
   PubMed Web of Science ®Google Scholar
• Yang Y, Ma J, Xiu J, Bai L, Guan F, Zhang L, Liu J, Zhang L. Deferoxamine compensates for decreases in B cell counts and reduces mortality in enterovirus 71-infected mice. Mar Drugs. 2014;12(7):4086–95. doi:10.3390/md12074086. PMID: 25003792; PMCID: PMC4113816.
   PubMedGoogle Scholar
• Ballas SK, Zeidan AM, Duong VH, DeVeaux M, Heeney MM. The effect of iron chelation therapy on overall survival in sickle cell disease and β-thalassemia: a systematic review. Am J Hematol. 2018;93(7):943–52. doi:10.1002/ajh.25103. Epub 2018 Apr 28. PMID: 29635754.
   PubMedGoogle Scholar
• Cappellini MD. Exjade(R) (deferasirox, ICL670) in the treatment of chronic iron overload associated with blood transfusion. Ther Clin Risk Manag. 2007;3(2):291–9. doi:10.2147/tcrm.2007.3.2.291. PMID: 18360637; PMCID: PMC1936310.
   PubMedGoogle Scholar
• Botzenhardt S, Li N, Chan EW, Sing CW, Wong IC, Neubert A. Safety profiles of iron chelators in young patients with haemoglobinopathies. Eur J Haematol. 2017;98(3):198–217. doi:10.1111/ejh.12833. Epub 2017 Jan 19. PMID: 27893170.
   PubMed Web of Science ®Google Scholar
• He T. Cardiovascular magnetic resonance T2* for tissue iron assessment in the heart. Quant Imaging Med Surg. 2014;4(5):407–12. doi: 10.3978/j.issn.2223-4292.2014.10.05. PMID: 25392825; PMCID: PMC4213428.
   PubMedGoogle Scholar
• Hynes MJ, O’Coinceanainn M. The kinetics and mechanisms of reactions of iron(III) with caffeic acid, chlorogenic acid, sinapic acid, ferulic acid and naringin. J Inorg Biochem. 2004;98(8):1457–64. doi: 10.1016/j.jinorgbio.2004.05.009. PMID: 15271524.
   PubMed Web of Science ®Google Scholar
• Genaro-Mattos TC, Maurício ÂQ, Rettori D, Alonso A, Hermes-Lima M . Correction: antioxidant activity of caffeic acid against iron-induced free radical generation-A chemical approach . PLoS One. 2015;10(11):e0142402. doi: 10.1371/journal.pone.0129963. Erratum in: PLoS One. 2015;10(11):e0142402. PMID: 26098639; PMCID: PMC4476807.
   PubMedGoogle Scholar
• Langland J, Jacobs B, Wagner CE, Ruiz G, Cahill TM. Antiviral activity of metal chelates of caffeic acid and similar compounds towards herpes simplex, VSV-Ebola pseudotyped and vaccinia viruses. Antiviral Res. 2018;160:143–50. doi: 10.1016/j.antiviral.2018.10.021. Epub 2018 Oct 28. PMID: 30393014.
   PubMed Web of Science ®Google Scholar
• Weng JR, Lin CS, Lai HC, Lin YP, Wang CY, Tsai YC, Wu KC, Huang SH, Lin CW. Antiviral activity of Sambucus FormosanaNakai ethanol extract and related phenolic acid constituents against human coronavirus NL63. Virus Res. 2019;273:197767. doi:10.1016/j.virusres.2019.197767. Epub 2019 Sep 24. PMID: 31560964; PMCID: PMC7114872.
   PubMed Web of Science ®Google Scholar
• Kumar V, Dhanjal JK, Kaul SC, Wadhwa R, Sundar D. Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (Mpro) of SARS-CoV-2 and inhibit its activity. J Biomol Struct Dyn. 2021;39(11):3842–54. doi: 10.1080/07391102.2020.1772108. Epub 2020 Jun 1. PMID: 32431217; PMCID: PMC7284143.
   PubMed Web of Science ®Google Scholar
• Adem Ş, Eyupoglu V, Sarfraz I, Rasul A, Zahoor AF, Ali M, Abdalla M, Ibrahim IM, Elfiky AA. Caffeic acid derivatives (CAFDs) as inhibitors of SARS-CoV-2: CAFDs-based functional foods as a potential alternative approach to combat COVID-19. Phytomedicine. 2021;85:153310. doi:10.1016/j.phymed.2020.153310. Epub 2020 Aug 22. PMID: 32948420; PMCID: PMC7442560.
   PubMed Web of Science ®Google Scholar
• Messner DJ, Surrago C, Fiordalisi C, Chung WY, Kowdley KV. Isolation and characterization of iron chelators from turmeric (Curcuma longa): selective metal binding by curcuminoids. Biometals. 2017;30(5):699–708. Epub 2017 Aug 11. PMID: 28801864; PMCID: PMC5955385. doi:10.1007/s10534-017-0038-6.
   PubMedGoogle Scholar
• Rainey NE, Moustapha A, Saric A, Nicolas G, Sureau F, Petit PX. Iron chelation by curcumin suppresses both curcumin-induced autophagy and cell death together with iron overload neoplastic transformation. Cell Death Discov. 2019;5:150. doi:10.1038/s41420-019-0234-y. PMID: 31839992; PMCID: PMC6901436.
   PubMedGoogle Scholar
• Jiao Y, Wilkinson J, 4th, C, Pietsch E, Buss JL, Wang W, Planalp R, Torti FM, Torti SV. Iron chelation in the biological activity of curcumin. Free Radic Biol Med. 2006;40(7):1152–60. doi: 10.1016/j.freeradbiomed.2005.11.003. PMID: 16545682.
   PubMed Web of Science ®Google Scholar
• Mursaleen L, Somavarapu S, Zariwala MG. Deferoxamine and curcumin loaded nanocarriers protect against rotenone-induced neurotoxicity. JPD. 2020;10(1):99–111. PMID: 31868679. doi:10.3233/JPD-191754.
   Google Scholar
• Liu Z, Ying Y. The inhibitory effect of curcumin on virus-induced cytokine storm and its potential use in the associated severe pneumonia. Front Cell Dev Biol. 2020;8:479. doi:10.3389/fcell.2020.00479. PMID: 32596244; PMCID: PMC7303286.
   PubMed Web of Science ®Google Scholar
• Lim L, Dang M, Roy A, Kang J, Song J. Curcumin allosterically inhibits the dengue NS2B-NS3 protease by disrupting its active conformation. ACS Omega. 2020;5(40):25677–86. doi:10.1021/acsomega.0c00039. PMID: 33073093; PMCID: PMC7557217.
   PubMed Web of Science ®Google Scholar
• Vajragupta O, Boonchoong P, Morris GM, Olson AJ. Active site binding modes of curcumin in HIV-1 protease and integrase. Bioorg Med Chem Lett. 2005;15(14):3364–8. doi:10.1016/j.bmcl.2005.05.032. PMID: 15950462.
   PubMed Web of Science ®Google Scholar
• Soni VK, Mehta A, Ratre YK, Tiwari AK, Amit A, Singh RP, Sonkar SC, Chaturvedi N, Shukla D, Vishvakarma NK. Curcumin, a traditional spice component, can hold the promise against COVID-19? Eur J Pharmacol. 2020;886:173551. doi:10.1016/j.ejphar.2020.173551. Epub 2020 Sep 12. PMID: 32931783; PMCID: PMC7832734.
   PubMed Web of Science ®Google Scholar
• Das S, Sarmah S, Lyndem S, Singha Roy A. An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study. J Biomol Struct Dyn. 2021;39(9):3347–57. doi:10.1080/07391102.2020.1763201. Epub 2020 May 13. PMID: 32362245; PMCID: PMC7232884.
   PubMed Web of Science ®Google Scholar
• Naidu SAG, Tripathi YB, Shree P, Clemens RA, Naidu AS. Phytonutrient inhibitors of SARS-CoV-2/NSP5-encoded main protease (Mpro) autocleavage enzyme critical for COVID-19 pathogenesis. J Diet Suppl. 2021;:1–28. Epub ahead of print. PMID: 34821532. doi:10.1080/19390211.2021.2006388.
   Google Scholar
• Rajagopal K, Varakumar P, Baliwada A, Byran G. Activity of phytochemical constituents of Curcuma longa (turmeric) and Andrographis paniculata against coronavirus (COVID-19): an in silico approach. Futur J Pharm Sci. 2020;6(1):104. doi:10.1186/s43094-020-00126-x. Epub 2020 Oct 16. PMID: 33215042; PMCID: PMC7562761.
   PubMed Web of Science ®Google Scholar
• Biewenga GP, Haenen GR, Bast A. The pharmacology of the antioxidant lipoic acid. Gen Pharmacol. 1997;29(3):315–31. doi:10.1016/s0306-3623(96)00474-0. PMID: 9378235.
   PubMedGoogle Scholar
• Camiolo G, Tibullo D, Giallongo C, Romano A, Parrinello NL, Musumeci G, Di Rosa M, Vicario N, Brundo MV, Amenta F, et al. α-Lipoic acid reduces iron-induced toxicity and oxidative stress in a model of iron overload. IJMS. 2019;20(3):609. PMID: 30708965; PMCID: PMC6387298. doi:10.3390/ijms20030609.
   Google Scholar
• Rochette L, Ghibu S, Richard C, Zeller M, Cottin Y, Vergely C. Direct and indirect antioxidant properties of α-lipoic acid and therapeutic potential. Mol Nutr Food Res. 2013;57(1):114–25. doi:10.1002/mnfr.201200608. PMID: 23293044.
   PubMed Web of Science ®Google Scholar
• Graf E, Empson KL, Eaton JW. Phytic acid. A natural antioxidant. J Biol Chem. 1987;262(24):11647–50. PMID: 3040709.
   PubMed Web of Science ®Google Scholar
• Zajdel A, Wilczok A, Węglarz L, Dzierżewicz Z. Phytic acid inhibits lipid peroxidation in vitro. Biomed Res Int. 2013;2013:147307. doi:10.1155/2013/147307. Epub 2013 Oct 24. PMID: 24260736; PMCID: PMC3821898.
   PubMedGoogle Scholar
• Kamp DW, Israbian VA, Yeldandi AV, Panos RJ, Graceffa P, Weitzman SA. Phytic acid, an iron chelator, attenuates pulmonary inflammation and fibrosis in rats after intratracheal instillation of asbestos. Toxicol Pathol. 1995;23(6):689–95. PMID: 8772254. doi:10.1177/019262339502300606.
   PubMed Web of Science ®Google Scholar
• Otake T, Mori H, Morimoto M, Miyano K, Ueba N, Oishi I, Kunita N, Kurimura T. Anti-HIV-1 activity of myo-inositol hexaphosphoric acid (IP6) and myo-inositol hexasulfate(IS6). Anticancer Res. 1999; Sep-Oct19(5A):3723–6. PMID: 10625947.
   PubMedGoogle Scholar
• Ayres JS. A metabolic handbook for the COVID-19 pandemic. Nat Metab. 2020;2(7):572–85. doi:10.1038/s42255-020-0237-2. Epub 2020 Jun 30. PMID: 32694793; PMCID: PMC7325641.
   PubMedGoogle Scholar
• Martínez-Reyes I, Chandel NS. Mitochondrial TCA cycle metabolites control physiology and disease. Nat Commun. 2020;11(1):102. doi:10.1038/s41467-019-13668-3. PMID: 31900386; PMCID: PMC6941980.
   PubMed Web of Science ®Google Scholar
• Mullen PJ, Garcia G, Jr, Purkayastha A, Matulionis N, Schmid EW, Momcilovic M, Sen C, Langerman J, Ramaiah A, Shackelford DB, et al. SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition. Nat Commun. 2021;12(1):1876. doi:10.1038/s41467-021-22166-4. PMID: 33767183; PMCID: PMC7994801.
   PubMed Web of Science ®Google Scholar
• Moghimi N, Di Napoli M, Biller J, Siegler JE, Shekhar R, McCullough LD, Harkins MS, Hong E, Alaouieh DA, Mansueto G, et al. The neurological manifestations of post-acute sequelae of SARS-CoV-2 infection. Curr Neurol Neurosci Rep. 2021;21(9):44. doi:10.1007/s11910-021-01130-1. PMID: 34181102; PMCID: PMC8237541.
   PubMedGoogle Scholar
• Parker AM, Brigham E, Connolly B, McPeake J, Agranovich AV, Kenes MT, Casey K, Reynolds C, Schmidt KFR, Kim SY, et al. Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care. Lancet Respir Med. 2021;9(11):1328–41. Epub 2021 Oct 19. PMID: 34678213; PMCID: PMC8525917. doi:10.1016/S2213-2600(21)00385-4.
   PubMed Web of Science ®Google Scholar
• Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, Villapol S. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144. doi:10.1038/s41598-021-95565-8. PMID: 34373540; PMCID: PMC8352980.
   PubMed Web of Science ®Google Scholar
• Ramadan MS, Bertolino L, Zampino R, Durante-Mangoni E, Durante-Mangoni E, Iossa D, Bertolino L, Ursi MP, D’Amico F, Karruli A, et al. Monaldi hospital cardiovascular infection study group. Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review. Clin Microbiol Infect. 2021;27(9):1250–61. Epub 2021 Jun 23. PMID: 34171458; PMCID: PMC8220864. doi:10.1016/j.cmi.2021.06.015.
   PubMedGoogle Scholar
• Gameil MA, Marzouk RE, Elsebaie AH, Rozaik SE. Long-term clinical and biochemical residue after COVID-19 recovery. Egypt Liver J. 2021;11(1):74. doi:10.1186/s43066-021-00144-1.Epub 2021 Sep 12. PMID: 34777873; PMCID: PMC8435147.
   PubMedGoogle Scholar